Veriteq (DIGA) 10-Q/A 17 Sep 14 2014 Q2 Quarterly report (amended) Financial data

Document_And_Entity_Informatio

Document And Entity Information	6 Months Ended
	Jun. 30, 2014	Aug. 15, 2014
Document and Entity Information [Abstract]	'	'
Entity Registrant Name	'VERITEQ	'
Document Type	'10-Q	'
Current Fiscal Year End Date	'--12-31	'
Entity Common Stock, Shares Outstanding	'	34,186,131
Amendment Flag	'true	'
Amendment Description	'We are filing this Amendment No. 1 on Form 10-Q/A (this "Amendment") to amend disclosure of net loss per share with respect to the following items in our Quarterly Report on Form 10-Q for the quarter ended June 30, 2014 as originally filed with the Securities and Exchange Commission on August 20, 2014 (the "Original Form 10-Q"): (i) the Statements of Operations for the three and six-months ended June 30, 2014 and 2013 and from December 14, 2011 (our inception) to June 30, 2014, (ii) footnotes 1 and 9 of the unaudited condensed consolidated financial statements, (iii) the signature page, (iv) the certifications of our Chief Executive and Chief Financial Officer, and (v) our financial statements formatted in XBRL in Exhibit 101. No other sections were affected, but for the convenience of the reader, this Amendment restates in its entirety, as amended, our Original Form 10-Q. In our Original Form 10-Q, the weighted average shares outstanding - basic and diluted and the resulting loss per common share attributable to common stockholders - basic and diluted, for the three and six-months ended June 30, 2014, did not correctly state the number of weighted-average shares outstanding due to a calculation error related to shares issuable under certain right to shares agreements that the Company entered into during June 2014. The effect of this error is presented below. No other qualitative or quantitative changes have been made to the financial statements. No event subsequent to August 20, 2014 is included in this Amendment. Consolidated Statements of Operations Data (in thousands, except per share data) For the Three-MonthsEndedJune 30,2014 As PreviouslyReported Correction For the Three-MonthsEndedJune 30,2014 As Restated Net loss per common share - basic and diluted $ (0.28 ) $ (0.12 ) $ (0.40 )Weighted average number of common shares outstanding - basic and diluted 19,913 (6,024 ) 13,889 For the Six-MonthsEnded June 30, 2014As PreviouslyReported Correction For the Six-MonthsEnded June 30, 2014As Restated Net loss per common share -- basic and diluted $ (0.06 ) $ (0.02 ) $ (0.08 )Weighted average number of common shares outstanding - basic and diluted 14,758 (3,002 ) 11,756	'
Entity Central Index Key	'0000924642	'
Entity Current Reporting Status	'Yes	'
Entity Voluntary Filers	'No	'
Entity Filer Category	'Smaller Reporting Company	'
Entity Well-known Seasoned Issuer	'No	'
Document Period End Date	30-Jun-14	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q2	'

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (Current Period Unaudited) (USD $)	Jun. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
ASSETS	'	'
Cash	$110	$13
Restricted cash	47	882
Accounts receivable	20	'
Inventory	26	21
Other receivable	'	171
Other current assets	48	96
Total current assets	251	1,183
Property and equipment, net	5	4
Other assets	69	14
Intangible assets, net	6,721	7,018
Total assets	7,046	8,219
LIABILITIES AND STOCKHOLDERS’ DEFICIT	'	'
Notes payable, net of discounts (including $216 and $60 to related parties, respectively)	1,250	467
Subordinated convertible debt with an embedded convertible option, at fair value	2,137	'
Liabilities for conversion option of the convertible notes	125	3,124
Accounts payable	1,057	854
Accrued expenses (including $2,386 and $1,764 to related parties, respectively)	3,580	2,718
Due to former related party under shared services agreement	217	211
Total current liabilities	8,366	7,374
Commitments and contingencies (Notes 11 and 12)	'	'
Subordinated convertible debt with an embedded convertible option, at fair value	'	4,925
Warrant liabilities at fair value	1,962	6,114
Contingent consideration – estimated royalty obligations	3,840	3,940
Total liabilities	14,168	22,353
Stockholders’ deficit:	'	'
Preferred Stock ($10 par value; shares authorized 5,000; 0 shares issued and outstanding)	'	'
Common shares ($0.01 par value; shares authorized 50,000; shares issued and outstanding, 41,480 and 9,459, respectively, including 29,097 shares issuable at June 30, 2014)	415	95
Additional paid-in-capital	13,220	5,595
Accumulated deficit during the development stage	-20,757	-19,824
Total stockholders’ deficit	-7,122	-14,134
Total liabilities and stockholders’ deficit	$7,046	$8,219

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) (USD $)	Jun. 30, 2014	Dec. 31, 2013
In Thousands, except Share data, unless otherwise specified
Notes payable, net of discounts to related parties (in Dollars)	$216	$60
Accrued expenses to related parties (in Dollars)	$2,386	$1,764
Preferred shares, par value (in Dollars per share)	$10	$10
Preferred shares, shares authorized	5,000,000	5,000,000
Preferred shares,shares outstanding	0	0
Preferred Shares, shares issued	0	0
Common shares, par value (in Dollars per share)	$0.01	$0.01
Common shares, shares authorized	50,000,000	50,000,000
Common shares, shares issued	41,480,000	9,459,000
Common shares, shares outstanding	41,480,000	9,459,000
Common shares, shares subscribed but unissued	29,097,000	'

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended				6 Months Ended				31 Months Ended
Share data in Thousands, except Per Share data, unless otherwise specified	Jun. 30, 2014		Jun. 30, 2013		Jun. 30, 2014		Jun. 30, 2013		Jun. 30, 2014
Sales	$21,000		'		$95,000		'		$113,000
Cost of goods sold	8,000		'		46,000		'		53,000
Gross margin	13,000		'		49,000		'		60,000
Operating Expenses:	'		'		'		'		'
Selling, general and administrative expenses	1,163,000		1,138,000		2,469,000		2,100,000		10,408,000
Development expenses	75,000		3,000		139,000		9,000		276,000
Depreciation and amortization expense	149,000		148,000		298,000		297,000		1,101,000
Total operating expenses	1,387,000		1,289,000		2,906,000		2,406,000		11,785,000
Operating Loss	-1,374,000		-1,289,000		-2,857,000		-2,406,000		-11,725,000
Other Income (Expense):	'		'		'		'		'
Change in value of convertible debt with embedded option feature	356,000		'		2,788,000		'		'
Change in fair value of conversion option of the convertible notes	2,558,000		'		3,628,000		'		3,265,000
Change in value of warrant liabilities	-5,961,000		'		-2,838,000		'		-4,107,000
Other expense	-6,000		'		-62,000		'		-169,000
Interest expense	-1,131,000		-253,000		-1,592,000		-446,000		-8,821,000
Total other income (expense)	-4,184,000		-253,000		1,924,000		-446,000		-9,832,000
Loss before income taxes	-5,558,000		-1,542,000		-933,000		-2,852,000		-21,557,000
Benefit for income taxes	0		0		0		0		800,000
Net Loss	($5,558,000)		($1,542,000)		($933,000)		($2,852,000)		($20,757,000)
Net loss per common share — basic and diluted (in Dollars per share)	($0.40)		($0.17)		($0.08)		($0.32)		'
Weighted average number of common shares outstanding — basic and diluted (in Shares)	13,889	[1]	9,042	[1]	11,756	[1]	8,941	[1]	'
[1]	The following stock options, warrants and shares issuable under right to shares agreements, investor relations consulting agreement and upon conversion of convertible notes payable outstanding at June 30, 2014 and 2013 were not included in the computation of dilutive loss per share because the net effect would have been anti-dilutive:

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements of Comprehensive (Loss) (Unaudited) (USD $)	3 Months Ended		6 Months Ended		31 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014
Net loss	($5,558)	($1,542)	($933)	($2,852)	($20,757)
Comprehensive loss	($5,558)	($1,542)	($933)	($2,852)	($20,757)

Condensed_Consolidated_Stateme2

Condensed Consolidated Statement of Changes in Stockholders’ Deficit (Unaudited) (USD $)

Series C Preferred Stock [Member]

Series C Preferred Stock [Member]

Series C Preferred Stock [Member]

Issuance Of Common Stock To Investors, April 2012 [Member]

Issuance Of Common Stock To Investors, April 2012 [Member]

Issuance Of Common Stock To Investors, April 2012 [Member]

Issuance Of Common Stock And Warrants To Investor, June 2012 [Member]

Issuance Of Common Stock And Warrants To Investor, June 2012 [Member]

Issuance Of Common Stock And Warrants To Investor, June 2012 [Member]

Issuance Of Common Stock Warrants, Convertible Notes Payable September 2012 [Member]

Issuance Of Common Stock Warrants, Convertible Notes Payable September 2012 [Member]

Beneficial Conversion Feature Of Convertible Note Payable September 2012 [Member]

Beneficial Conversion Feature Of Convertible Note Payable September 2012 [Member]

Issuance Of Common Stock Warrants, Convertible Notes Payable October 2012 [Member]

Issuance Of Common Stock Warrants, Convertible Notes Payable October 2012 [Member]

Beneficial Conversion Feature Of Convertible Note Payable, October 2012 [Member]

Beneficial Conversion Feature Of Convertible Note Payable, October 2012 [Member]

Issuance Of Common Stock Warrants, Convertible Notes Payable, December 2012 [Member]

Issuance Of Common Stock Warrants, Convertible Notes Payable, December 2012 [Member]

Beneficial Conversion Feature Of Convertible Note Payable, December 2012 [Member]

Beneficial Conversion Feature Of Convertible Note Payable, December 2012 [Member]

Issuance Of Common Stock And Warrants For Note Conversion March 2013 [Member]

Issuance Of Common Stock And Warrants For Note Conversion March 2013 [Member]

Issuance Of Common Stock And Warrants For Note Conversion March 2013 [Member]

Issuance Of Common Stock And Warrants For Note Conversion June 2013 [Member]

Issuance Of Common Stock And Warrants For Note Conversion June 2013 [Member]

Issuance Of Common Stock And Warrants For Note Conversion June 2013 [Member]

Issuance of common stock for investment advisory services, July 2013 [Member]

Issuance of common stock for investment advisory services, July 2013 [Member]

Issuance of common stock for investment advisory services, July 2013 [Member]

Issuance Of Common Stock For Partial Note Conversion October 2013 [Member]

Issuance Of Common Stock For Partial Note Conversion October 2013 [Member]

Issuance Of Common Stock For Partial Note Conversion October 2013 [Member]

Issuance Of Common Stock For Investor Relations Octover 2013 [Member]

Issuance Of Common Stock For Investor Relations Octover 2013 [Member]

Issuance Of Common Stock For Investor Relations Octover 2013 [Member]

Issuance Of Common Stock For Investor Relations, November 2013 [Member]

Issuance Of Common Stock For Investor Relations, November 2013 [Member]

Issuance Of Common Stock For Investor Relations, November 2013 [Member]

Issuance Of Common Stock For Partial Note Conversion, February 2014 [Member]

Issuance Of Common Stock For Partial Note Conversion, February 2014 [Member]

Issuance Of Common Stock For Partial Note Conversion, February 2014 [Member]

Issuance Of Common Stock For Cashless Exercise Of Warrant, February 2014 [Member]

Issuance Of Common Stock For Cashless Exercise Of Warrant, February 2014 [Member]

Issuance Of Common Stock For Cashless Exercise Of Stock Options March 2014 [Member]

Issuance Of Common Stock For Cashless Exercise Of Stock Options March 2014 [Member]

Rights To Shares Agreement [Member]

Rights To Shares Agreement [Member]

Rights To Shares Agreement [Member]

Preferred Stock [Member]

Common Stock [Member]

Common Stock [Member]

Common Stock [Member]

Common Stock [Member]

Additional Paid-in Capital [Member]

Additional Paid-in Capital [Member]

Additional Paid-in Capital [Member]

Additional Paid-in Capital [Member]

Accumulated Deficit during Development Stage [Member]

Convertible Notes Payable [Member]

VeriTeQ Corporation [Member]

Total

Preferred Stock [Member]

Common Stock [Member]

Additional Paid-in Capital [Member]

Common Stock [Member]

Additional Paid-in Capital [Member]

Investors [Member]

Common Stock [Member]

Additional Paid-in Capital [Member]

Investors [Member]

Additional Paid-in Capital [Member]

USD ($)

Additional Paid-in Capital [Member]

USD ($)

Additional Paid-in Capital [Member]

USD ($)

Additional Paid-in Capital [Member]

USD ($)

Additional Paid-in Capital [Member]

USD ($)

Additional Paid-in Capital [Member]

USD ($)

Common Stock [Member]

Additional Paid-in Capital [Member]

USD ($)

Common Stock [Member]

Additional Paid-in Capital [Member]

USD ($)

Common Stock [Member]

Additional Paid-in Capital [Member]

USD ($)

Common Stock [Member]

Additional Paid-in Capital [Member]

USD ($)

Common Stock [Member]

Additional Paid-in Capital [Member]

USD ($)

Common Stock [Member]

Additional Paid-in Capital [Member]

USD ($)

Common Stock [Member]

Additional Paid-in Capital [Member]

USD ($)

Common Stock [Member]

Additional Paid-in Capital [Member]

Common Stock [Member]

Additional Paid-in Capital [Member]

Common Stock [Member]

Additional Paid-in Capital [Member]

USD ($)

USD ($)

Restricted Stock [Member]

Convertible Notes Payable [Member]

VeriTeQ Corporation [Member]

USD ($)

Restricted Stock [Member]

Convertible Notes Payable [Member]

VeriTeQ Corporation [Member]

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

Investors [Member]

Investors [Member]

USD ($)

Investors [Member]

Investors [Member]

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

Balance at Dec. 31, 2011

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Net loss

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

($1,605,000)

'

'

($1,605,000)

Issuances of common stock for founders shares, January 2012

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

56,000

'

'

'

-56,000

'

'

'

'

Issuances of common stock for founders shares, January 2012 (in Shares)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

5,563,000

'

'

'

'

'

'

'

'

Issuance of common stock and assumption of stock options for acquisition

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

8,000

'

'

'

752,000

'

'

'

760,000

Issuance of common stock and assumption of stock options for acquisition (in Shares)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

763,000

'

'

'

'

'

'

'

'

Issuance of common stock

'

'

'

2,000

78,000

80,000

'

15,000

15,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Issuance of common stock (in Shares)

'

'

'

218,000

'

'

41,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Issuance of common stock for services

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

4,000

'

'

'

156,000

'

'

'

160,000

Issuance of common stock for services (in Shares)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

436,000

'

'

'

'

'

'

'

'

Issuance of common stock and warrants for note conversion

'

'

'

'

'

'

'

'

'

33,000

33,000

'

'

34,000

34,000

'

'

41,000

41,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Beneficial conversion feature of convertible note payable

'

'

'

'

'

'

'

'

'

'

'

33,000

33,000

'

'

34,000

34,000

'

'

41,000

41,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based compensation

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

354,000

'

'

'

354,000

Balance at Dec. 31, 2012

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

70,000

'

'

'

1,515,000

-1,623,000

'

'

-38,000

Balance (in Shares) at Dec. 31, 2012

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

7,021,000

'

'

'

'

'

'

'

'

Net loss

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

-18,201,000

'

'

-18,201,000

Issuance of Restricted Stock

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

9,000

'

'

'

-9,000

'

'

'

'

'

'

'

Issuance of Restricted Stock (in Shares)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

859,000

'

'

'

'

'

'

'

'

'

'

'

Issuance of common stock and assumption of stock options for acquisition

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

10,000

'

'

'

925,000

'

'

'

935,000

'

Issuance of common stock and assumption of stock options for acquisition (in Shares)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,029,000

'

'

'

'

'

'

'

'

'

Issuance of common stock

4,108,000

-82,000

-4,026,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

25,000

'

'

'

25,000

Issuance of common stock (in Shares)

411,000

-8,215,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

19,000

'

'

'

'

'

'

'

'

Issuance of common stock for services

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,000

62,000

63,000

'

'

'

1,000

90,000

91,000

1,000

262,000

263,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Issuance of common stock for services (in Shares)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

42,000

'

'

'

'

'

33,000

'

'

130,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Issuance of common stock and warrants for note conversion

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,000

194,000

195,000

2,000

439,000

441,000

'

'

'

'

25,000

25,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

-4,108,000

'

'

'

82,000

'

'

'

4,026,000

'

'

'

'

Issuance of common stock and warrants for note conversion (in Shares)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

95,000

'

'

221,000

'

'

'

'

'

17,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

-411,000

'

'

'

8,215,000

'

'

'

'

'

'

'

'

Adjustments to APIC

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

-16,000

'

'

'

-16,000

Adjustments to APIC (in Shares)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

-7,000

'

'

'

'

'

'

'

'

Issuance of warrants in connection with payable

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

35,000

'

'

'

35,000

Share-based compensation

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2,048,000

'

'

'

2,048,000

Balance at Dec. 31, 2013

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

95,000

'

'

'

5,595,000

-19,824,000

'

'

-14,134,000

Balance (in Shares) at Dec. 31, 2013

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

9,459,000

'

'

'

'

'

'

'

'

Net loss

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

-933,000

'

'

-933,000

Issuance of Restricted Stock

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

7,000

'

'

'

-7,000

'

'

'

1,500,000

Issuance of Restricted Stock (in Shares)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

650,000

'

'

'

'

'

'

'

'

Issuance of common stock

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,000

-1,000

'

'

11,000

-11,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Issuance of common stock (in Shares)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

67,000

'

'

'

1,120,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Issuance of common stock for cashless exercise of stock options, March 2014

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3,000

-3,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Issuance of common stock for cashless exercise of stock options, March 2014 (in Shares)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

363,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

382,000

Issuance of common stock and warrants for note conversion

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

70,000

70,000

'

'

'

'

10,000

181,000

191,000

'

'

7,000

'

'

'

128,000

'

'

'

135,000

'

'

Issuance of common stock and warrants for note conversion (in Shares)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

47,000

'

'

'

'

'

'

961,000

'

'

'

'

677,000

'

'

'

'

'

'

'

'

'

'

Adjustments to APIC

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

281,000

6,709,000

6,990,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Adjustments to APIC (in Shares)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

28,136,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Issuance of warrants in connection with payable

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

66,000

'

'

'

66,000

Beneficial conversion feature of convertible note payable

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

139,000

'

'

'

139,000

Share-based compensation

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

354,000

'

'

'

354,000

Balance at Jun. 30, 2014

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$415,000

'

'

'

$13,220,000

($20,757,000)

'

'

($7,122,000)

Balance (in Shares) at Jun. 30, 2014

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

41,480,000

'

'

'

'

'

'

'

'

Condensed_Consolidated_Stateme3

Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	6 Months Ended		31 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014
Cash flows from operating activities:	'	'	'
Net loss	($933,000)	($2,852,000)	($20,757,000)
Share based compensation	354,000	916,000	2,756,000
Depreciation and amortization	298,000	297,000	1,101,000
Non-cash interest expense	1,568,000	413,000	8,320,000
Change in fair value of subordinated convertible debt	-2,788,000	'	'
Change in fair value of warrants	2,838,000	'	3,558,000
Change in fair value of conversion option of the convertible notes	-3,628,000	'	-3,265,000
Loss on settlement of other receivable	56,000	'	56,000
Deferred income tax benefit	'	'	-800,000
Issuance of warrants for contract amendment	66,000	'	'
Realized loss on sale of marketable securities, available-for-sale	'	'	107,000
Change in other receivable	115,000	'	169,000
Change in other current assets	23,000	'	-49,000
Change in accounts payable, accrued expenses and liability under shared services agreement	978,000	979,000	4,463,000
Change in other assets	-55,000	-10,000	-65,000
Net cash used in operating activities	-1,174,000	-257,000	-3,440,000
Cash flows from investing activities:	'	'	'
Purchases of fixed assets	-1,000	'	-5,000
Sale of marketable securities, available-for-sale	'	'	133,000
Cash acquired from acquisition of VeriTeQ Corporation (f/k/a Digital Angel Corporation)	'	'	818,000
Net cash (used in) provided by investing activities	-1,000	'	946,000
Cash flows from financing activities:	'	'	'
Proceeds from the issuances of notes payable, net of repayments of $33 in 2014	537,000	50,000	997,000
Proceeds from the issuance of common stock to investors	'	25,000	105,000
Proceeds from the issuance of senior convertible debt, net of repayments of $400 in 2014	-100,000	'	1,550,000
Change in restricted cash	835,000	'	-47,000
Cash paid in lieu of fractional shares	'	'	-16,000
Proceeds from the issuance of common stock and warrants to investor	'	'	15,000
Net cash provided by financing activities	1,272,000	75,000	2,604,000
Net increase (decrease) in cash	97,000	-182,000	110,000
Cash --- Beginning of period	13,000	183,000	'
Cash — End of period	110,000	1,000	110,000
Warrant [Member]	'	'	'
Cash flows from operating activities:	'	'	'
Issuance of warrants for contract amendment	'	'	550,000
Common Stock [Member]	'	'	'
Cash flows from operating activities:	'	'	'
Issuance of common stock for investment advisory and investor relation services	'	'	$416,000

Condensed_Consolidated_Stateme4

Condensed Consolidated Statements of Cash Flows (Unaudited) (Parentheticals) (USD $)	6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014
Notes payable, repayments	$33

Note_1_Organization_and_Summar

Note 1 - Organization and Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2014
Accounting Policies [Abstract]	'
Significant Accounting Policies [Text Block]	'
	1. Organization and Summary of Significant Accounting Policies
	These unaudited condensed consolidated financial statements and notes thereto, include the financial statements of VeriTeQ Corporation (“VC” or the "Company"), formerly known as Digital Angel Corporation, and its wholly-owned subsidiary, VeriTeQ Acquisition Corporation (“VAC”), a Florida corporation formed on December 14, 2011. VC became the legal acquirer of VAC and VAC became the accounting acquirer of VC pursuant to the terms of a share exchange agreement (the “Exchange Agreement”), as more fully discussed below. In January 2012, VAC acquired all of the outstanding stock of PositiveID Animal Health Corporation, a Florida corporation, from PositiveID Corporation (“PSID”), which at the time was a related party. In December 2012, VAC formed a subsidiary, VTQ IP Holding Corporation, a Delaware corporation. VC, VAC and VAC’s subsidiaries are referred to together as, “VeriTeQ,” “the Company,” “we,” “our,” and “us”. Our business consists of ongoing efforts to provide implantable medical device identification and radiation dose measurement technologies to the healthcare industry.
	The accompanying condensed consolidated financial statements of the Company have been prepared in accordance with United States (“U.S.”) generally accepted accounting principles (“GAAP”) and with the instructions to Form 10-Q and Article 8 of Regulation S-X under the Securities Exchange Act of 1934, as amended. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The interim financial information in this report has not been audited. In the opinion of the Company’s management, all adjustments (consisting of normal recurring adjustments) considered necessary for fair financial statement presentation have been made. Results of operations reported for interim periods may not be indicative of the results for the entire year. These condensed consolidated financial statements and notes should be read in conjunction with the consolidated financial statements and notes for the year ended December 31, 2013 included in our Annual Report for Form 10-K as amended, filed with the Securities and Exchange Commission (“SEC”) on August 19, 2014.
	Restatement and Amendment of Previously Issued Financial Statements
	In our Original Form 10-Q filed with the SEC on August 20, 2014, the weighted average shares outstanding – basic and diluted and the resulting loss per common share attributable to common stockholders – basic and diluted, for the three and six-months ended June 30, 2014, did not correctly state the number of weighted-average shares outstanding due to a calculation error related to shares issuable under certain right to shares agreements that the Company entered into during June 2014.   The effect of this error is presented below.  No other qualitative or quantitative changes have been made to the financial statements. No event subsequent to August 20, 2014 is included in this Amendment.
	Consolidated Statements of Operations Data
	(in thousands, except per share data)
			For the Three-Months			Correction			For the Three-Months
			Ended						Ended
			June 30,						June 30,
			2014 As Previously						2014 As Restated
			Reported
	Net loss per common share — basic and diluted		$	(0.28	)	$	(0.12	)	$	(0.40	)
	Weighted average number of common shares outstanding – basic and diluted			19,913			(6,024	)		13,889
			For the Six-Months Ended			Correction			For the Six-Months Ended
			30-Jun-14						30-Jun-14
			As Previously Reported						As Restated
	Net loss per common share -- basic and diluted		$	(0.06	)	$	(0.02	)	$	(0.08	)
	Weighted average number of common shares outstanding – basic and diluted			14,758			(3,002	)		11,756
	During the preparation of the Company’s Form 10-Q for the period ended June 30, 2014, an error was identified for the accounting of the Company's financing transaction in November 2013 which is described below. On August 19, 2014, the Company has restated and amended its consolidated financial statements for the year ended December 31, 2013 on Form 10-K/A and on August 20, 2014, the Company amended its financial statements as of and for three months ended March 31, 2014 on Form 10-Q/A to correct for impact of this error.
	On November 13, 2013, the Company entered into a financing transaction, as more fully discussed in Note 5 to the accompanying financial statements, which included notes in the principal amount of $1,816,667. The notes are convertible into shares of the Company’s common stock at an initial exercise price of $0.75 per share. The notes provided for the initial conversion price to be reset to lower amounts in the event the Company issues its common stock or is deemed to have issued its common stock at a price below the conversion price in effect at that time. This provision results in what is referred to as an embedded derivative and should have been bifurcated and a liability recorded at fair value upon the issuance of the notes and on December 31, 2013 and on March 31, 2014. This oversight resulted in an understatement of the derivative liability of $2.1 million and $3.1 million at March 31, 2014 and December 31, 2013, respectively.
	Going Concern
	The accompanying financial statements have been prepared assuming we will continue as a going concern, which contemplates the realization of assets and the liquidation of liabilities in the normal course of business. We are in the development stage, have incurred operating losses since our inception and have a working capital deficit. Our cash position is critically low, and payments critical to our survival are not being made in the ordinary course. Failure to raise capital in the coming days to fund our operations and generate positive cash flow to fund such operations will have a material adverse effect on our financial condition. These factors raise substantial doubt about our ability to continue as a going concern. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might result from this uncertainty. Further, the report of the independent registered public accounting firm on the Company’s December 31, 2013 financial statements included a paragraph about the existence of substantial doubt concerning the Company’s ability to continue as a going concern.
	We need to raise additional funds immediately and continuing until we begin to ship sufficient quantities of our products to fund our operations and we may not be able to obtain debt or equity funding at all, or if available, they may not be on favorable terms.
	Although we had negative working capital at June 30, 2014, we are attempting to generate enough cash from: (i) capital raises; (ii) the additional issuances of promissory notes, including to related parties; (iv) business operations as we have begun to ship our products; (v) through other investing and financing sources; (vi) from our ability to continue to delay certain salary and bonus payments to senior management until funds are available; and (vii) to undertake other cash management initiatives, including working with our vendors to continue to allow us to extend payment terms in order to operate our business for the twelve months ending June 30, 2015.
	Our goal is to achieve profitability and to generate positive cash flows from operations. Our capital requirements depend on a variety of factors, including but not limited to, the cash that will be required to grow our business operations and to service our debt. Failure to raise additional capital to fund our operations and to generate positive cash flow from such operations will have a material adverse effect on our financial condition, results of operations and cash flows.
	Development Stage
	The Company is in the development stage as defined by Accounting Standards Codification subtopic 915-10 Development Stage Entities ("ASC 915-10") and its success depends on its ability to obtain financing and realize its marketing efforts. To date, the Company has generated only a small amount of revenue, has incurred expenses and has sustained operating losses. Consequently, its operations are subject to all the risks inherent in the establishment of a new business enterprise. For the period from December 14, 2011 (Inception) through June 30, 2014, the Company has accumulated losses of approximately $20.8 million.
	Share Exchange Agreement and Reverse Stock Split
	On June 24, 2013, VAC and its stockholders entered in the Exchange Agreement with VC and the closing of the transaction (the “VeriTeQ Transaction”) took place on July 8, 2013 (the “Closing Date”). Pursuant to the terms of the Exchange Agreement, VAC exchanged all of its issued and outstanding shares of common stock for 4,107,592 shares of VC’s Series B Convertible Preferred Stock (the “Series B Preferred Stock”). On July 10, 2013, VC realized that it incorrectly issued the Series B Preferred Stock and as a result, on July 12, 2013, it exchanged the Series B Preferred Stock for 410,759 shares of its newly created Series C convertible preferred stock, par value $10.00 (the “Series C Preferred Stock”). The terms of the Series C Preferred Stock are substantially similar to the Series B Preferred Stock, including the aggregate number of shares of common stock into which the Series C Preferred Stock was convertible. Each share of Series C Preferred Stock was convertible into twenty shares of VC’s common stock, par value $0.01 per share (the “Conversion Shares”), automatically upon the effectiveness of the Reverse Stock Split (defined below) on October 18, 2013 (such transaction is sometimes referred to herein as the “Share Exchange”).
	Under the terms of the Exchange Agreement, all outstanding stock options to purchase shares of VAC’s common stock, whether or not exercisable or vested, converted into options to acquire shares of VC’s common stock (the “Substitute Options”), and all outstanding warrants to purchase shares of VAC’s common stock converted into warrants to purchase shares of VC’s common stock (the “Converted Warrants”). As a result of the Share Exchange and the issuance of the Substitute Options and the Converted Warrants, VAC became a wholly-owned subsidiary of VC, and VAC’s shareholders owned on July 12, 2013 approximately 91% of VC’s common stock, on an as converted, fully diluted basis (including outstanding stock options and warrants).
	Based on the terms of the transaction, VAC was the accounting acquirer and as a result VAC’s operating results became the historical operating results of the Company. In addition, VAC’s common stock has been presented as if it was converted into shares of VC’s common stock at the beginning of the periods presented herein and based on the exchange ratio under the terms of the Exchange Agreement, which was 0.19083. The exchange ratio took into consideration the Reverse Stock Split, which is more fully discussed below.
	The Series C Preferred Stock consisted of 500,000 authorized shares, 410,759 of which were issued and outstanding through October 17, 2013. The shares of Series C Preferred Stock issued to VAC’s shareholders in connection with the Share Exchange, by their principal terms:
	(a)	converted into a total of 8,215,184 Conversion Shares, constituting approximately 88% of the issued and outstanding shares of common stock of VC, following the Reverse Stock Split on October 18, 2013 (as more fully discussed below);
	(b)	had the same voting rights as holders of VC’s common stock on an as-converted basis for any matters that are subject to stockholder vote;
	(c)	were not entitled to any dividends; and
	(d)	were to be treated pari passu with the common stock on liquidation, dissolution or winding up of VC.
	On July 12, 2013, VC obtained approval from a majority of its shareholders for and to effect a one for thirty (1:30) reverse stock split (the “Reverse Stock Split”). On October 18, 2013, VC filed a Certificate of Amendment to its Certificate of Incorporation with the Secretary of State of the State of Delaware to effect the Reverse Stock Split. The Reverse Stock Split became effective on October 18, 2013. The Reverse Stock Split caused the total number of shares of common stock outstanding, including the shares underlying the Series C Preferred Stock, to equal 9,302,674 shares of VC common stock based on the shares outstanding on October 18, 2013. The Reverse Stock Split did not affect the number of shares of VC’s authorized common stock, which remain at 50 million shares.
	As a result of the Reverse Stock Split, all share information in this Quarterly Report has been restated to reflect the Reverse Stock Split as if it had occurred at the beginning of the periods presented, where appropriate.
	In connection with the Share Exchange, Digital Angel Corporation changed its name to VeriTeQ Corporation effective October 18, 2013.
	On July 12, 2013, pursuant to the Exchange Agreement, a majority of VC’s voting stockholders adopted resolutions by written consent approving the Digital Angel Corporation 2013 Stock Incentive Plan (the “DAC 2013 Stock Plan”), under which employees, including officers and directors, and consultants may receive awards. The Plan became effective on October 18, 2013.
	Amended and Restated Certification of Incorporation and Adoption of 2014 Stock Incentive Plan
	On June 18, 2014, the Company obtained approval from a majority of its stockholders to:
		●	increase the number of authorized shares of the Company’s common stock from 50 million to 500 million;
		●	reduce the par value of the Company’s preferred stock from $10.00 per share to $0.01 per share; and
		●	adopt the Company’s 2014 Stock Incentive Plan under which 50 million shares are reserved for issuance.
	The Company expects to file an Amended and Restated Certificate of Incorporation with the State of Delaware to effect the changes to its authorized shares of common stock and the par value of its preferred stock and to complete the adoption of the 2014 Stock Incentive Plan on or about August 26, 2014.
	A portion of the increase in the authorized shares of the Company’s common stock became necessary as a result of a financing that occurred on May 30, 2014. As described in the following paragraph, that financing triggered resets in the pricing of convertible promissory notes issued by the Company on November 13, 2013, and triggered changes to the exercise price and number of shares covered by warrants issued in connection with such notes.
	Under the terms of the May 30, 2014 financing, the Company issued promissory notes totaling $0.3 million to two investors. The promissory notes are convertible into shares of the Company’s common stock at an exercise price of $0.20 per share. As a result of the May 30, 2014 financing, certain reset provisions under the terms of existing promissory notes convertible into shares of the Company’s common stock and existing common stock warrants, which were issued on November 13, 2013, were triggered. Accordingly, the conversion price of the convertible promissory notes with an aggregate principal balance of $1,816,667 was reset to $0.20 per share from $0.75 per share of the Company’s common stock and the exercise price of the common stock warrants was changed to $0.20 per share from $2.84 per share of the Company’s common stock. In addition, the number of common stock warrants was increased from common stock warrants to acquire 2,944,444 shares of the Company’s common stock to common stock warrants to acquire 41,811,114 shares of the Company’s common stock, subject to adjustment based on the cashless provisions of the warrants.
	On June 10, 2014, a Right to Shares Agreement was entered into with one of the holders of a promissory note and common stock warrant issued on November 13, 2013 and reset on May 30, 2014 as discussed above. The warrant holder was entitled to receive 15,199,410 warrant shares under the cashless exercise provisions of its common stock warrant but agreed to accept the lesser amount of 11,500,000 warrant shares in full satisfaction of the complete exercise of its warrant of which 495,711 shares of common stock were issued on June 13, 2014 and 474,000 shares of common stock were issued on June 27, 2014, leaving a balance remaining to be issued of 10,530,289 shares of the Company’s common stock at June 30, 2014. Subsequent to June 30, 2014 and through August 15, 2014, we have issued an additional 10,035,289 shares of the Company’s common stock under the agreement and 495,000 shares remained to be issued. The balance will be issued from time to time at the election of the holder, subject to limitations regarding the holder’s percentage of beneficial ownership, for no additional consideration.
	On June 24, 2014, a Right to Shares Agreement was entered into with one of the holders of a promissory note and common stock warrant issued on November 13, 2013 and reset on May 30, 2014. Pursuant to the agreement, the Company and the shareholder acknowledged that the shareholder desired to (1) exchange the shareholder warrant, for a right to acquire 17,763,325 shares of common stock to be issued to the shareholder, with such right being determined based on the cashless exercise formula contained in the warrant; (2) redeem $400,000 underlying its promissory note for $400,000 in cash, and (3) convert $190,667 underlying its promissory note into 953,334 shares of common stock. Pursuant to the agreement, the shareholder has a right to receive 18,716,659 shares of common stock, and the balance of the shareholder’s remaining note that was issued on November 13, 2013 has been reduced to $190,667. The issuance of shares of the Company’s common stock will be made from time to time, subject to limitations regarding the holder’s percentage of beneficial ownership, for no additional consideration. As of June 30, 2014, we issued 150,000 shares under the June 24, 2014 Right to Shares Agreement and 18,566,659 shares of the Company common stock remained to be issued. From July 1, 2014 to August 15, 2014, we issued an additional 9,118,000 shares of the Company’s common stock under the agreement and 9,448,659 shares of the Company’s common stock remain to be issued.
	Letter Agreement with Digital Angel Radio Communications Limited. (DARC)
	On January 30, 2014, we and the buyers of Digital Angel Radio Communications Limited, or DARC (a former wholly-owned subsidiary operating in the United Kingdom), entered into a letter agreement under which we agreed to accept a payment of £62,000 (approximately $0.1 million) in full and final settlement of a deferred purchase price related to VC’s sale of DARC in March 2013. As a result, we recorded a loss of approximately USD $56,000 in the six-months ended June 30, 2014. The loss is included in other expense in our condensed consolidated statement of operations. All other provisions (including, without limitation, the indemnities) agreed between VC, and/or the buyers under the stock purchase agreement and any related documents remain in full force and effect.
	Summary of Significant Accounting Policies
	Principles of Consolidation
	The financial statements include our accounts and the accounts of our subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.
	Classification of Expenses
	For comparative purposes, we have reclassified certain expenses related to the development of our products from selling, general and administrative expenses to development expenses in the historical financial statement presented herein.
	Use of Estimates
	The preparation of financial statements in conformity with generally accepted accounting principles (“GAAP”) in the United States of America (“U.S.”) requires management to make certain estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Although these estimates are based on the knowledge of current events and actions we may undertake in the future, they may ultimately differ from actual results. Included in these estimates are assumptions used in determining the lives of long-lived assets, in Black-Scholes-Merton (“BSM”) valuation models in estimating the fair value of stock-based compensation and warrants, promissory notes with an embedded convertible option and royalty obligations and in determining valuation allowances for intangible assets, deferred tax assets, among others.
	Concentration of Credit Risk
	We maintained our domestic cash in two financial institutions during the period ended June 30, 2014. Balances were insured up to Federal Deposit Insurance Corporation limits of $250,000 per institution. At times, cash balances may exceed the federally insured limits.
	Other Current Assets
Other current assets consist primarily of deferred financing costs of approximately $20,000 at June 30, 2014 and prepaid insurance of approximately $28,000 and $74,000 at June 30, 2014 and December 31, 2013, respectively. No other items included in other current assets at June 30, 2014 and December 31, 2013 exceeded 5% of total current assets, respectively.
Inventory
Inventory consisted of purchased finished goods at June 30, 2014 and December 31, 2013. Inventory is valued at the lower of the value using the first-in, first-out (“FIFO”) cost method, or market.
Property and Equipment
Property and equipment, consisting primarily of computer equipment, and are stated at cost less accumulated depreciation. Depreciation expense is computed using the straight-line method over the estimated useful life of the related assets (generally three years for computer equipment and 10 years for other equipment). Depreciation expense for the three-months ended June 30, 2014 and 2013 was approximately $1 thousand and nil, respectively. Depreciation expense for the six-months ended June 30, 2014 and 2013 was approximately $1 thousand and nil, respectively.
Intangible Assets
We account for intangible assets in accordance with the Intangibles — Goodwill and Other Topic of the Codification. Intangible assets deemed to have an indefinite life, such as goodwill, are reviewed at least annually for impairment. Intangible assets with finite lives are amortized over their estimated useful lives. We do not have any intangible assets with indefinite lives.
We have intangible assets consisting of technology, customer relationship and trademarks, which are more fully discussed in Note 3. These intangible assets are amortized over their expected economic lives ranging from 7 to 14 years. The lives were determined based upon the expected use of the asset, the ability to extend or renew patents, trademarks and other contractual provisions associated with the asset, the stability of the industry, expected changes in and replacement value of distribution networks and other factors deemed appropriate. We continually evaluate whether events or circumstances have occurred that indicate the remaining estimated useful lives of our definite-lived intangible assets warrant revision or that the remaining balance of such assets may not be recoverable. We use an estimate of the related undiscounted cash flows over the remaining life of the asset in measuring whether the asset is recoverable. We believe that no impairment of our intangible assets existed as of June 30, 2014.
Revenue Recognition
Product revenue is recognized at the time product is shipped and title has transferred, provided that a purchase order has been received or a contract has been executed, there are no uncertainties regarding customer acceptance, the sales price is fixed and determinable and collectability is deemed probable. If uncertainties regarding customer acceptance exist, we intend to recognize the revenue when such uncertainties are resolved. There are no significant post-contract support obligations at the time of revenue recognition. Our accounting policy regarding vendor and post contract support obligations is based on the terms of the customers’ contracts and is billable upon occurrence of the post-sale support. Currently, there are no multiple element arrangements in connection with our product sales. Cost of products sold is recorded as the related revenue is recognized. We offer a warranty on our products and record a liability for product warranties at the time it is probable that a warranty liability has been incurred and the amount of loss can reasonably be estimated. To date, we have not incurred a warranty liability on products we have sold. It is our policy to approve all customer returns before issuing credit to the customer.
Stock-Based Compensation
At June 30, 2014, we had five stock-based employee compensation plans which are more fully described in Note 7 to our consolidated financial statements included in our Annual Report on Form 10-K filed with the SEC on April 15, 2014. In accordance with the Compensation – Stock Compensation Topic of the Codification, awards granted are valued at fair value and compensation cost is recognized on a straight line basis over the service period of each award. On June 18, 2014, our majority stockholders approved the 2014 Stock Incentive Plan, which is more fully discussed in Note 7.
Income Taxes
We recognize deferred tax liabilities and assets for the expected future tax consequences of events that have been included in the financial statement or tax returns. Under this method, deferred tax liabilities and assets are determined based on the difference between financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Temporary differences between taxable income reported for financial reporting purposes and income tax purposes consist primarily of timing differences such as amortization of intangible assets, deferred officers' compensation and stock-based compensation. A valuation allowance is provided against net deferred tax assets where we determine realization is not currently judged to be more likely than not. We recognize and measure uncertain tax positions through a two-step process. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount which is more than 50% likely of being realized upon ultimate settlement. We consider many factors when evaluating and estimating tax positions and tax benefits, which may require periodic adjustments and which may not accurately anticipate actual outcomes. Accordingly, we report a liability for unrecognized tax benefits resulting from the uncertain tax positions taken or expected to be taken in a tax return and recognize interest and penalties, if any, related to uncertain tax positions in income tax expense.
Loss Per Common Share and Common Share Equivalent
Basic and diluted loss per common share has been computed by dividing the loss by the weighted average number of common shares outstanding. Since we have incurred losses attributable to common stockholders, diluted loss per common share has not been computed by giving effect to all potentially dilutive common shares that were outstanding during the period., since to do so would have been anti-dilutive. See Note 9 for the computation of basic and diluted loss per share.
Impact of Recently Issued Accounting Standards
From time to time, the Financial Accounting Standards Board (“FASB”) or other standards setting bodies will issue new accounting pronouncements. Updates to the FASB Accounting Standards Codification (“ASC” or “Codification”) are communicated through issuance of an Accounting Standards Update (“ASU”).
In June 2014, the FASB issued ASU Codification Development Stage Entities (Topic 915), Elimination of Certain Financial Reporting Requirements, Including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation. The amendments related to the elimination of inception-to date information and other remaining disclosure requirements of Topic 915, which should be applied retrospectively and are effective for annual reporting periods beginning after December 15, 2014 and interim periods therein. The amendments also clarify that the guidance in Topic 275, Risks and Uncertainties, is applicable to entities that have not commenced planned principal operations. The amendments regarding Topic 275 and the sufficiency-of-equity-at-risk criterion for development stage entities of Topic 810 shall be applied prospectively. The adoption of these amendments will eliminate the inception--to–date information that is currently presented in the Company’s financial statements and may result in enhanced disclosures regarding risks and uncertainties applicable to the Company’s business.
In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update No. 2014-09,”Revenue from Contracts with Customers (Topic 606),” (“ASU 2014-09”). ASU 2014-09 outlines a new, single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. This new revenue recognition model provides a five-step analysis in determining when and how revenue is recognized. The new model will require revenue recognition to depict the transfer of promised goods or services to customers in an amount that reflects the consideration a company expects to receive in exchange for those goods or services. ASU 2014-09 is effective for public entities for annual reporting periods beginning after December 15, 2016 and interim periods within those periods. Early adoption is not permitted. Companies may use either a full retrospective or a modified retrospective approach to adopt ASU 2014-09. The Company is currently assessing the impact that adopting this new accounting guidance will have on its consolidated financial statements and footnote disclosures.

Note_2_Acquisition

Note 2 - Acquisition	6 Months Ended
	Jun. 30, 2014
Disclosure Text Block Supplement [Abstract]	'
Mergers, Acquisitions and Dispositions Disclosures [Text Block]	'
	2. Acquisition
	Acquisition	Dates		Acquisition		Intangible		Description of Assets
		Acquired		Price		Assets
						Acquired
	(in thousands)
	VeriTeQ Corporation	7/8/13		$	935	$	—	Cash, marketable securities and receivables, among others
	Acquisition of VeriTeQ Corporation under Share Exchange Agreement
	Given VAC’s former shareholders’ ownership in VC, as a result of the Exchange Agreement, VAC was considered to be the acquirer for accounting purposes and the transaction was accounted for as a reverse acquisition of VC by VAC under the accounting rules for business combinations. Accordingly, VC’s assets and liabilities were recorded at their estimated fair values to the extent they were deemed to have been acquired for accounting purposes and VC has established a new basis for its assets and liabilities based upon the fair values thereof and the value of VC’s shares outstanding on July 8, 2013, the Closing Date.
	The results of VC have been included in the consolidated statements of operations since July 8, 2013, the date of acquisition. Unaudited pro forma results of operations for the six-months ended June 30, 2013 are included below. Such pro forma information assumes that the VC acquisition had occurred as of January 1, 2013. This summary is not necessarily indicative of what our result of operations would have been had VC been a combined entity during such period, nor does it purport to represent results of operations for any future periods.
	(In thousands, except per share amounts)		Six-Months
			Ended June 30,
			2013
	Net operating revenue		$	—
	Loss from continuing operations		$	(3,208	)
	Loss per common share from continuing operations– basic and diluted		$	(0.35	)

Note_3_Intangible_Assets

Note 3 - Intangible Assets	6 Months Ended
	Jun. 30, 2014
Disclosure Text Block [Abstract]	'
Intangible Assets Disclosure [Text Block]	'
	3. Intangible Assets
	Intangibles and other assets consist of the following:
		June 30,		December 31,		Lives
		2014		2013		(in years)
		(in thousands)		(in thousands)
	Technology, net of accumulated amortization of $873 and $627	$	5,998	$	6,244		14
	Customer relationship, net of accumulated amortization of $176 and $141		324		359		7
	Trademarks, net of accumulated amortization of $51 and $35		399		415		14
		$	6,721	$	7,018
	Amortization of intangibles charged against income amounted to $0.1 million and $0.1 million for the three-months ended June 30, 2014 and 2013, respectively, and $0.3 million and $0.3 million for the six-months ended June 30, 2014 and 2013, respectively.

Note_4_Accrued_Expenses

Note 4 - Accrued Expenses	6 Months Ended
	Jun. 30, 2014
Other Liabilities and Financial Instruments Subject to Mandatory Redemption [Abstract]	'
Other Liabilities Disclosure [Text Block]	'
	4. Accrued Expenses
	The following table summarizes the significant components of accrued expenses:
		June 30,		December 31,
		2014		2013
		(in thousands)
	Accrued payroll and payroll related	$	2,315	$	1,734
	Accrued legal		454		445
	Accrued other expenses		811		539
	Total accrued expenses	$	3,580	$	2,718

Note_5_Notes_Payable_and_Restr

Note 5 - Notes Payable and Restricted Cash	6 Months Ended
	Jun. 30, 2014
Debt Disclosure [Abstract]	'
Debt Disclosure [Text Block]	'
	5. Notes Payable and Restricted Cash
	November 2013 Financing Transaction
	On November 13, 2013, we entered into the securities purchase agreement (the “Purchase Agreement”) with a group of institutional investors (the “Investors”), relating to the private placement of approximately $1,816,667 in principal amount of senior secured convertible promissory notes. The notes were issued with an original issue discount of $166,667 and the aggregate purchase price of the notes was $1,650,000. Notwithstanding the purchase price of $1,650,000, $150,000 of the purchase price was be deemed paid at the closing by the cancellation of $150,000 of obligations owed by the Company to the placement agent as more fully discussed below. Therefore, the Notes were issued for a cash purchase price of $1,500,000, and with warrants to purchase up to 2,422,222 shares of our common stock, on the terms set forth below.
	In connection with the financing, we agreed to allow our placement agent to participate in the offering for $150,000 in lieu of our obligation to pay the placement agent a cash fee of $150,000. In addition, the placement agent will receive 5% of the aggregate cash exercise price received by us upon exercise of any warrants in the offering, and they received 222,222 warrants entitling them to purchase 222,222 shares of common stock as part of their placement agent fee. Thus, the aggregate number of warrants, issued in the financing was 2,644,444. We also issued 300,000 warrants under the terms of a letter agreement dated November 13, 2013 in connection with the financing. Thus, the warrants issued on November 13, 2013 aggregated 2,944,444.
	In connection with the sale of the notes and the warrants issued to the Investors, (i) we entered into a registration rights agreement with the Investors (the "Registration Rights Agreement"), (ii) we and certain of our subsidiaries entered into a security and pledge agreement in favor of the collateral agent for the Investors (the "Security Agreement"), (iii) certain of our subsidiaries entered into a guaranty in favor of the collateral agent for the Buyers (the “Guaranty”), and (iv) we and each depository bank in which such bank account is maintained entered into certain account control agreements with respect to certain accounts described in the Note and the Security Agreement. The transaction closed on November 13, 2013 (the “Closing”).
	At Closing, we received proceeds, net of $115,000 of the Investor’s expenses that were paid for by the Company, of $635,000 and approximately $750,000 of the proceeds were placed in restricted bank accounts in amounts proportionate to each Investors note balance. The restricted funds were to be applied to pay any redemption or other payment due under the applicable note to the applicable holder from time to time. Per the term of the securities purchase agreement, we were required upon the sale of 50,000 shares of MGT Capital Investments Inc.’s common stock that we owned to place the proceeds from the sale into the restricted bank accounts on a pro rata basis. Accordingly, on November 21, 2013, upon the sale of the 50,000 shares of MGT’s common stock under the terms of a stock purchase agreement, we placed approximately $132,500 into the restricted accounts. The balance in the restricted bank accounts totaled approximately $0.9 million at March 31, 2014. On April 3, 2014 and on June 16, 2014, to provide the Company with additional liquidity, several of the Investors transferred approximately $145 thousand and $0.3 million, respectively, of the restricted funds to our operating account. In connection with the Right to Shares Agreement dated June 24, 2014, $0.4 million of the restricted funds were used to pre-pay a portion of one of the outstanding notes. Therefore, the balance in the restricted accounts aggregates approximately $47 thousand as of June 30, 2014.
	Under the terms of a May 30, 2014 financing, the Company issued promissory notes totaling $0.3 million to two of the Investors. The promissory notes are convertible into shares of the Company’s common stock at an exercise price of $0.20 per share. As a result of the May 30, 2014 financing, certain reset provisions under the terms of the November 13, 2013 promissory notes were triggered. Accordingly, the conversion price of the notes with an aggregate principal balance of $1,816,667 was reset to $0.20 per share from $0.75 per share of the Company’s common stock and the exercise price of certain warrants issued on November 13, 2014, was changed to $0.20 per share from $2.84 per share of the Company’s common stock. In addition, the number of warrants was increased from common stock warrants to acquire 2,944,444 shares of the Company’s common stock to warrants to acquire 41,811,114 shares of the Company’s common stock, subject to adjustment based on the cashless provisions of the warrants. On June 10, 2014 and June 24, 2014, the Company entered into Right to Shares Agreements with two of the Investors related to the notes and warrants. The Right to Shares Agreements are more fully discussed in Note 1.
	Notes payable consists of the following (in thousands, except per share amounts):
			June 30,			December 31,
			2014			2013
			(in thousands)
	Note originally with PSID for $200 dated January 11, 2012, bore interest at 5% per annum, was originally payable in monthly instalments beginning January 11, 2013 through December 11, 2014. Note was amended in July 2013 to allow for conversion into common stock and extend payment terms. After the note was partially converted into common stock in October 2013, PSID assigned the note to a group of lenders in November 2013. One of the lenders converted $60 of the note and $10 of accrued interest into 47 shares of common stock in February 2014. The Company issued warrants to acquire 300 shares of its common stock to PSID in connection with a letter agreement entered into in November 2013, that were reset on May 30, 2014 to warrants to acquire 4,260 shares at an exercise price of $0.20 per share. (2)(3)		$	115		$	175
	Demand note for $80 issued October 11, 2013 to our CEO, bears interest at 5% per annum repaid in November 2013, February and April 2014(1)			—			30
	Demand note for $30 issued October 29, 2013 to our CEO, bears interest at 5% per annum, partially repaid in April 2014(1)			26			30
	Senior Secured Convertible Notes issued November 13, 2013 for $1,817, of which $726 was repaid or converted in June 2014, net of discount of $400 and $1,585, to group of institutional investors, are convertible into shares of common stock at $0.20 per share and mature November 13, 2014. Notes were issued with Warrants to acquire 2,644 shares of common stock with an exercise price of $2.84 per share that were reset on May 30, 2014 to warrants to acquire 37,551 shares of common stock with an exercise price of $0.20 per share of which 11,254 were outstanding on June 30, 2014. (2)(4)			691			232
	Demand note for $60 issued January 8, 2014 to Michael Krawitz, our CFO, bears interest at 5% per annum (1)			60			—
	Demand note for $60 issued January 16, 2014 to our CEO, bears interest at 5% per annum (1)			60			—
	Demand note for $40 issued January 16, 2014 to our President, bears interest at 5% per annum (1)			40			—
	Note for $175 issued on February 4, 2014 to Corbin Properties LLC, bears interest at 10% per annum, due February 4, 2015			175			—
	Demand note for $25 issued March 4, 2014 to a Director, bears interest at 5% per annum (1)			25			—
	Note for $25 issued March 5, 2014 to Deephaven Enterprises, Inc., net of discount of $22, bears interest at 9% per annum, due March 5, 2015. Effective May 30, 2014, the note became convertible into shares of common stock at a price of $0.35 per share.			3			—
	Note for $25 issued on March 6, 2014, to James Rybicki Trust, net of discount of $22, bears interest at 9% per annum, due March 6, 2015. Effective May 30, 2014, the note became convertible into shares of common stock at a price of $0.35 per share.			3			—
	Note for $25 issued on March 10, 2014, to William Caragol, net of discount of $25, bears interest at the rate of 9% per annum, due March 10, 2015. Effective May 30, 2014, the note became convertible into shares of common stock at a price equal to 60% of the lowest closing bid price over the 10-trading days immediately preceding a conversion notice.			—			—
	Note for $61 issued on March 20, 2014 to Deephaven Enterprises, Inc., net of discount of $43, bears interest at the rate of 9% per annum, due March 20, 2015. Effective May 30, 2014, existing outstanding common stock warrants held by the holder became exercisable at $0.35 per share and an additional 300 warrants to acquire shares of the Company’s common stock with an exercise price of $0.35 per share were granted. (2)			18			—
	Note for $25 issued April 16, 2014 to William Caragol, net of discount of $23, bears interest at 9% per annum, due April 16, 2015. Effective May 30, 2014, the note became convertible into shares of common stock at a price of $0.35 per share if conversion is elected by the holder or 60% of the lowest closing bid price over the 10-trading days immediately preceding a conversion notice if elected by the Company.			2			—
	Note for $30 issued on April 16, 2014, to Ned Siegel, net of discount of $27, bears interest at 9% per annum, due April 16, 2015. Effective May 30, 2014, the note became convertible into shares of common stock at a price of $0.35 per share. (1)			3			—
	Note for $20 issued on May 1, 2014, to Ned Siegel, net of discount of $18, bears interest at the rate of 9% per annum, due March 10, 2015. Effective May 30, 2014, the note became convertible into shares of common stock at a price of $0.35 per share. The note was issued with 100 warrants to acquire shares of the Company’s common stock with an exercise price of $0.35 per share. (1) (2).			2			—
	Senior Convertible Note for $222 issued May 30, 2014 to an Investor, net of discount of $203, convertible into shares of common stock at $0.20 per share and matures May 30, 2015. Note was issued with an original issue discount of $22 in lieu of interest. (4)			19			—
	Senior Convertible Note for $100 issued on May 30, 2014 to an Investor, net of discount of $92, convertible into shares of common stock at $0.20 per share, bears no interest, due May 30, 2015. (4)			8			—
	Total notes payable			1,250			467
	Less: Current maturities			(1,250	)		(467	)
	Note payable long-term		$	—		$	—
	Subordinated Convertible Note Payable elected at fair value:
	Non-interest bearing subordinated convertible note payable with a principal amount of $3,300 dated December 3, 2012. Note is convertible into common stock equal to 1/3 of the shares beneficially held by the CEO on the date of conversion. Note was amended in July 2013 to extend the maturity date to June 2015. The note was recorded at its fair value and will be revalued at each reporting period with changes in the fair value recorded as other expense/income.		$	2,137		$	4,925
	-1	These notes have been issued to related parties. See Note 10.
	-2	The warrants are more fully described in Note 7.
	-3	This note when originally issued was issued to a related party. See Note 10.
	-4	If and whenever we issue or sell, or are deemed to have issued or sold, any shares of common stock for a consideration per share less than a price equal to the conversion price in effect immediately prior to such issue or sale or deemed issuance or sale (the foregoing a “Dilutive Issuance”), then, immediately after such Dilutive Issuance, the conversion price then in effect shall be reduced to an amount equal to the new issuance price. The convertible option of these notes was bifurcated from the notes and recorded as its fair value on the date of issuance and at each reporting date, with the change in the fair value being charged/credited to other income/expense. Subsequent to June 30, 2014, the conversion price of the notes was reset as more fully discussed in Note 14.
	Interest expense was approximately $1.1 million and $0.3 million for the three-months ended June 30, 2014 and June 30, 2013, respectively, and $1.6 million and $0.4 million for the six-months ended June 30, 2014 and 2013, respectively. The majority of the interest expense is due to the accretion of debt discounts and, therefore, the weighted average interest rates for each of the periods are not meaningful numbers.
	See Note 14 for promissory notes issued subsequent to June 30, 2014.

Note_6_Financial_Instruments

Note 6 - Financial Instruments	6 Months Ended
	Jun. 30, 2014
Disclosure Text Block Supplement [Abstract]	'
Financial Instruments Disclosure [Text Block]	'
	6. Financial Instruments
	Fair Value Measurements
	We define fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities, which are required to be recorded at fair value, we consider the principal or most advantageous market in which we would transact and the market-based risk measurements or assumptions that market participants would use in pricing the asset or liability, such as inherent risk, transfer restrictions and credit risk.
	We apply the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement:
	Level 1 – Quoted prices in active markets for identical assets or liabilities.
	Level 2 – Observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
	Level 3 – Inputs that are generally unobservable and typically reflect management’s estimates of assumptions that market participants would use in pricing the asset or liability.
	During the three and six-months ended June 30, 2014, the subordinated convertible note, which has a convertible option embedded in the note, the conversion option of the convertible notes warrant liabilities and the contingent royalty obligations, which relate to assets acquisitions during 2012, were valued using Level 3 inputs, and for the three and six-months ended June 30, 2013, the subordinated convertible note and the contingent royalty obligations were valued using Level 3 inputs. The changes in fair value of the subordinated convertible note, the conversion option of the convertible notes and the warrant liabilities during the three and six-months ended June 30, 2014 and 2013 are reflected in other income (expense) for each period. There was no change in the estimated fair value of the contingent royalty obligations during the three and six-months ended June 30, 2014 and 2013.
	Notes Payable and Long-Term Debt
	At June 30, 2014 and December 31, 2013, we valued the subordinated convertible note based on the greater of the initial fair value as determined by a discounted cash flow methodology and the market value of the shares of our common stock into which it is convertible. We valued the conversion option of the convertible notes at fair value.
	Warrant Liabilities
	The carrying amounts approximate management’s estimate of the fair value of the warrant liabilities at June 30, 2014 based on the BSM valuation model and using the following assumptions: expected term of 4.37 years, expected volatility of 166%, risk-free interest rates of 1.25%, and expected dividend yield of 0%.
	Conversion option of the notes
	The carrying amounts approximates management's estimate of the embedded conversion option at June 30, 2014 and December 31, 2013 based on using a Monte Carlo method with the following assumptions: Market price of $0.14 and $2.29; terms of 0.42, 0.92 and 0.92 years; Standard deviation of 0.09, 0.11 and 0.18; and conversion price of $0.20 and $0.75, respectively.
	Estimated Royalty Obligations
	The carrying amount approximates management’s estimate of the fair value of royalty obligations that will be paid (discounted at rates ranging from 25% to 60%) for a period from 3 to 14 years.
	The following table summarizes our financial assets and liabilities measured at fair value as presented in the consolidated balance sheets as of June 30, 2014 and December 31, 2013 (in thousands):
		30-Jun-14									31-Dec-13
		Level 1			Level 2			Level 3			Level 1			Level 2		Level 3
	Liabilities:
	Subordinated convertible note with an embedded conversion option	$	—		$	—		$	2,137		$	—		$	—	$	4,925
	Embedded conversion option of the convertible notes	$	—		$	—		$	125		$	—		$	—	$	3,124
	Warrant liabilities	$	—		$	—		$	1,962		$	—		$	—	$	6,114
	Royalty obligations	$	—		$	—		$	4,000		$	—		$	—	$	4,000
	The following is a summary of activity of Level 3 liabilities for the six-months ended June 30, 2014 (in thousands):
		Subordinated			Embedded Conversion Option of Convertible Notes			Warrant			Estimated
		Note with						Liabilities			Royalty
		Convertible									Obligations
		Option
	Balance at December 31, 2013	$	4,925		$	3,124		$	6,114		$	4,000
	Increase due to embedded conversion option for May 30, 2014 convertible notes payable		—			629			—			—
	Change in fair value		(2,788	)		(3,628	)		2,838			—
	Exercise of warrants under Right to Shares Agreements		—						(6,990	)		—
	Balance at June 30, 2014	$	2,137	(1)	$	125		$	1,962		$	4,000	-2
	(1) The principal balance at December 31, 2013 and June 30, 2014 is $3.3 million. See Note 5 for additional information regarding the note.
	(2) Includes $160 thousand of current royalty obligations in account payable and accrued expenses at June 30, 2014.
	The Company’s management considers the carrying values of other current assets and other current liabilities to approximate fair values primarily due to their short-term nature.

Note_7_Stockholders_Deficit

Note 7 - Stockholders' Deficit	6 Months Ended
	Jun. 30, 2014
Stockholders' Equity Note [Abstract]	'
Stockholders' Equity Note Disclosure [Text Block]	'
	7. Stockholders’ Deficit
	Preferred Stock
	As of June 30, 2014, the Company has authorized 5,000,000 shares of preferred stock, par value $10.00 per share of which 500,000 shares were authorized as Series C Preferred Stock. The Series C Preferred Stock is more fully described in Note 1. No shares of preferred stock were outstanding as of June 30, 2014.
	Common Stock
	At June 30, 2014, VC had authorized 50 million shares of common stock of which approximately 12.4 million were issued and outstanding. Of the 12.4 million issued and outstanding shares of common stock at June 30, 2014, 5.7 million were beneficially owned by our Chief Executive Officer.
	On or about August 26, 2014, the Company intends to file an Amended and Restated Certification of Incorporation with the State of Delaware to increase the number of authorized shares of its common stock to 500 million and to reduce the par value of its preferred stock to $0.01 per share as more fully discussed in Notes 1 and 14.
	Warrants
	We have issued warrants exercisable for shares of common stock for consideration, as follows (in thousands, except exercise price):
	Series/ Issue Date	Warrants			Additional			Exercised			Balance				Exercise		Exercisable
		Issued/As			Warrants						June 30,				Price		Period
		Reset			under						2014						(years)
					Cashless
					Exercise
					Provisions
	Series A /June 2012		95			—			(95	)		—			$	0.37		3
	Series B / September 2012		40			—			—			40			$	1.57		3
	Series C / October 2012		20			—			—			20			$	1.57		3
	Series C / October 2012, reset May 2014		20			—			—			20			$	0.35		3
	Series D / December 2012		14			—			—			14			$	1.57		5
	Series E /December 2012		29			—			—			29			$	1.57		5
	Series F / March 2013		40			—			—			40			$	1.57		3
	Series G / April 2013		47		−−				—			47			$	1.31		3
	Series G / April 2013, reset May 2014		48		−−				—			48			$	0.35		3
	Series H / June 2013		63		−−				—			63			$	1.57		3
	Series H/ June 2013, reset May 2014		20		−−				—			20			$	0.35		3
	Series VT a/ November 2013, as reset May 2014		37,551			2,966			(29,263	)		11,254			$	0.2		5
	Series VT b/ November 2013, as reset May 2014		4,260			—			—			4,260			$	0.2		5
	Series I/ May 2014		300			—			—			300			$	0.35		3
	Series J/ May 2014		100			—			—			100			$	0.35		2
			42,647			2,966			(29,358	)		16,255
	The Series A warrant was issued in connection with a stock subscription agreement to an investor. The Series A warrant was exercised in February 2014 under the cashless exercise provisions of the warrants.
	The Series B, C, D, E, F, G and H warrants were issued in connection with promissory notes. These warrants are exercisable at any time during the exercisable periods. The warrant agreements provide for the number of shares to be adjusted in the event of a stock split, a reverse stock split, a share exchange or other conversion or exchange event in which case the number of warrants and the exercise price of the warrants shall be adjusted on a proportional basis. The total value of these warrants of approximately $0.3 million was amortized to interest expense over the life of the promissory notes. The promissory notes were converted into common stock during 2013. As a result of the issuances of two promissory notes on May 30, 2014, and under the terms of a promissory note issued on March 20, 2014, the exercises prices of one-half of the Series C, G and H warrants were reduced to $0.35 per share of common stock from exercise prices ranging from $1.31 to $1.57 per share. We recorded non-cash interest expense of approximately $7 thousand during the three-months ended June 30, 2014 as a result of the reductions in the exercise prices of the warrants.
	The Series VTa warrants were issued on November 13, 2013 in connection with senior secured convertible notes, which are more fully described in Note 5. These warrants are exercisable at any time during the exercise periods. The warrant agreements provide for the number of shares to be adjusted in the event of a stock split, a reverse stock split, a share exchange or other conversion or exchange event in which case the number of warrants and the exercise price of the warrants shall be adjusted on a proportional basis. In addition, if we issue or sell any shares of our common stock, except certain specified issuances pursuant to the Company’s stock plans or the issuance of common stock pursuant to agreements existing on November 13, 2013, at a price per share, or the New Exercise Price, less than the Exercise Price in effect immediately before the issuance or sale, then immediately after such dilutive issuance, the Exercise Price will be reduced to the New Exercise Price. If there is an adjustment to the Exercise Price as a result of any of the dilution events specified in the Warrant agreements, the number of shares of common stock that may be purchased upon exercise of the warrant will be increased or decreased proportionately, so that after such adjustment the aggregate Exercise Price payable for the adjusted number of shares shall be the same as the aggregate Exercise Price in effect immediately prior to such adjustment (without regard to any limitations on exercise). As a result of the issuances of two promissory notes on May 30, 2014, the reset provisions under the terms of the Series VTa warrants were triggered. Accordingly, the number of warrants to acquire shares of the Company’s common stock increased from 2,644,444 warrants to 37,551,144 warrants and the exercise price was reduced to $0.20 per share from $2.84 per share of common stock. In addition, during the three-months ended June 30, 2014, certain of the Series VTa warrants were exercised under the cashless provisions of the warrants, which resulted in an increase in the shares issued upon exercise as noted in the table above. Subsequent to June 30, 2014, the number of warrants and the exercise price have been reset as more fully discussed in Note 14.
	The Series VTb warrants were issued November 13, 2013 to PSID in connection with a letter agreement between the Company and PSID as more fully discussed in Note 10 to our consolidated financial statements included in our Annual Report on Form 10-K filed with the SEC on April 15, 2014. The terms of the Series VTb warrants are identical to the Series VTa warrants. As a result of the issuances of two promissory notes on May 30, 2014, the reset provisions under the terms of the Series VTb warrants were triggered. Accordingly, the number of warrants to acquire shares of the Company’s common stock increased from 300,000 warrants to 4,260,000 warrants and the exercise price was reduced to $0.20 per share from $2.84 per share of common stock. Subsequent to June 30, 2014, the number of warrants and the exercise price have been reset as more fully discussed in Note 14.
	The VTa and VTb warrants are classified as liabilities at June 30, 2014 and December 31, 2013.
	The Series I and J warrants were issued in connection with promissory notes issued on March 20, 2014 and May 1, 2014, respectively. As a result of the issuances of two promissory notes on May 30, 2014, provisions under the notes issued on March 20, 2014, and May 1, 2014 requiring the issuances of these warrants were triggered. These warrants are exercisable at any time during the exercise periods. The warrant agreements provide for the number of shares to be adjusted in the event of a stock split, a reverse stock split, a share exchange or other conversion or exchange event in which case the number of warrants and the exercise price of the warrants shall be adjusted on a proportional basis. The relative fair value of these warrants of approximately $0.1 million is being amortized to interest expense over the life of the promissory notes.
	We determined the value of the warrants issued in 2012, 2013 and 2014 on the issuance/reset dates utilizing the following assumptions in the BSM valuation model:
	Dates Warrants Issued/Reset	Dividend			Volatility			Expected			Risk-Free			Date of the
		Yield						Lives (Yrs.)			Rate			Assumptions
	Jun-12		0	%		126	%		3			0.34	%	1-Jun-12
	Sep-12		0	%		126	%		3			0.35	%	25-Sep-12
	Oct-12		0	%		126	%		3			0.35	%	12-Oct-12
	October 2012, reset May 2014		0	%		223	%		1.37			0.1	%	30-May-14
	Dec-12		0	%		126	%		5			0.72	%	31-Dec-12
	Mar-13		0	%		126	%		3			0.38	%	18-Mar-13
	Apr-13		0	%		126	%		3			0.34	%	10-Apr-13
	April 2013, reset May 2014		0	%		210	%		1.87			0.37	%	30-May-14
	Jun-13		0	%		126	%		3			0.52	%	1-Jun-13
	June 2013, reset May 2014		0	%		215	%		2.01			0.37	%	30-May-14
	November 2013, reset May 2014		0	%		163	%		4.46			1.54	%	30-May-14
	May 2014 (Series I)		0	%		192.26	%		2.8			0.79	%	30-May-14
	May 2014 (Series J)		0	%		214.78	%		2			0.39	%	30-May-14
	Stock Option Activity
	We had stock-based employee plans outstanding as of June 30, 2014, which are more fully described in Note 7 to our consolidated financial statements included in our Annual Report on Form 10-K/A filed with the SEC on August 19, 2014.
	We account for our stock-based compensation plans in accordance with ASC 718-10, Compensation – Stock Compensation. Under the provisions of ASC 718-10, the fair value of each stock option is estimated on the date of grant using a BSM option-pricing formula, and amortized to expense over the expected performance or service periods using the straight-line attribution method. During the three and six-months ended June 30, 2014 and for the three-months ended June 30, 2013, we did not grant any stock options. During the six-months ended June 30, 2013, we granted 1.0 million options The weighted average fair value of the options granted during the six-months ended June 30, 2013 was $1.33 per share.
	The weighted average values of the assumptions used to value the options granted in the six-months ended June 30, 2013 were as follows: expected term of 5 years, expected volatility of 126%, risk-free interest rates of 0.83%, and expected dividend yield of 0%. The expected life represents an estimate of the weighted average period of time that options are expected to remain outstanding given consideration to vesting schedules and the Company’s historical exercise patterns. Expected volatility was estimated based on the historical volatility of similar companies’ common stock. The risk free interest rate was estimated based on the U.S. Federal Reserve’s historical data for the maturity of nominal treasury instruments that corresponds to the expected term of the option. The expected dividend yield was 0% based on the fact that we have never paid dividends and we have no present intention to pay dividends.
	During the three and six-months ended June 30, 2014, we did not record any compensation expense associated with stock options as they were all fully vested on or before January 1, 2014. During the three and six-months ended June 30, 2013, we recorded approximately $0.4 million and $0.6 million in compensation expense related to stock options granted to our directors, employees and consultants (who provide corporate support services).
	A summary of the stock option activity for our stock options plans for the six-months ended June 30, 2014 is as follows (shares in thousands):
		Stock			Weighted			Weighted			Aggregate
		Options			Average			Average			Intrinsic
					Exercise			Contractual			Value
					Price			Term
								(years)
Outstanding at January 1, 2014		2,628		$	9.01
Granted		—			—
Exercised		(382	)		0.05
Forfeited or expired		(8	)		659.87
Outstanding at June 30, 2014		2,238			8.02			4.65		$	77,000	*
Vested or expected to vest at June 30, 2014		2,238			8.02			4.65		$	77,000	*
Shares available on June 30, 2014 for options that may be granted		2,508
*The intrinsic value of a stock option is the amount by which the market value of the underlying stock exceeds the exercise price of the option. The market value of our common stock was $0.14 per share at June 30, 2014.
There were 0.4 million stock options exercised during the six-months ended June 30, 2014, with a total intrinsic value of $0.4 million. No stock options were exercised during the three-months ended June 30, 2014 nor for the three and six-months ended June 30, 2013. No options vested during the three-months ended June 30, 2014 and 2013. The total fair value of options vested during the six-months ended June 30, 2013, was approximately $0.4 million. As of June 30, 2014, there was no unrecognized compensation cost related to stock options granted under our plans.
Restricted Stock Grants
In June 2014, we issued approximately 0.6 million shares of our restricted stock to a director as an inducement to joining our board. One-hundred and fifty-thousand shares of the restricted stock vest on January 2, 2015 and the remainder vest on January 3, 2016. Also, in January 2013, we issued approximately 0.9 million shares of our restricted common stock to a member of our senior management. This restricted stock vests in full in January 2015. The total value of the restricted stock of approximately $1.5 million is being expensed over the vesting period. During the three-months ended June 30, 2014 and 2013 and the six-months ended June 30, 2014 and 2013, we recorded $0.2 million, $0.2 million, $0.4 million and $0.3 million, respectively, in compensation expense related to the restricted stock.

Note_8_Income_Taxes

Note 8 - Income Taxes	6 Months Ended
	Jun. 30, 2014
Income Tax Disclosure [Abstract]	'
Income Tax Disclosure [Text Block]	'
	8. Income Taxes
	We did not have an income tax provision or benefit for the three and six-months ended June 30, 2014 and 2013. The income tax benefit of $0.8 million for the period from December 31, 2011 (Inception) to June 30, 2014 resulted from the utilization of deferred tax assets to offset a deferred tax liability associated with an acquisition we made in January 2012. We have incurred accumulated losses and have provided a valuation allowance against our net operating loss carryforwards and other net deferred tax assets.
	At June 30, 2014, we had estimated U.S. net operating loss carryforwards of approximately $11 million for income tax purposes, which expire in varying amounts through 2034. The amount of any benefit from our U.S. tax net operating losses is dependent on: (1) our ability to generate future taxable income, and (2) the unexpired amount of net operating loss carryforwards available to offset amounts payable on such taxable income. Any greater than a fifty percent change in ownership under IRC section 382 places significant annual limitations on the use of our U.S. net operating losses to offset any future taxable U.S. income we may generate. The change in the number of warrants outstanding on May 30, 2014 as a result of the reset provisions of warrants that we issued on November 13, 2013, as more fully discussed in Notes 1 and 5, resulted in a greater than fifty percent change in ownership under IRC section 382. Accordingly, our current net operating losses are limited in use to approximately $7.5 million, based on our preliminary estimates. Certain future transactions could again cause a more than fifty percent ownership change, including (a) additional issuances of shares of common stock by us or (b) acquisitions or sales of shares by certain holders of our shares, including persons who have held, currently hold, or accumulate in the future five percent or more of our outstanding stock.

Note_9_Loss_Per_Share

Note 9 - Loss Per Share	6 Months Ended
	Jun. 30, 2014
Earnings Per Share [Abstract]	'
Earnings Per Share [Text Block]	'
	9. Loss Per Share
	A reconciliation of the numerator and denominator of basic and diluted loss per share is provided as follows, in thousands, except per share amounts:
			Three-Months Ended						Six-Months Ended
			June 30,						June 30,
			2014			2013			2014			2013
			As Restated						As Restated
	Numerator for basic and diluted loss per share:
	Loss from continuing operations		$	(5,558	)	$	(1,542	)	$	(933	)	$	(2,852	)
	Denominator for basic and diluted loss per share:
	Basic and diluted weighted-average shares outstanding (1)			13,889			9,042			11,756			8,941
	Loss per share— basic and diluted:
	Total — basic and diluted		$	(0.40	)	$	(0.17	)	$	(0.08	)	$	(0.32	)
		-1	The following stock options, warrants and shares issuable under right to shares agreements, investor relations consulting agreement and upon conversion of convertible notes payable outstanding at June 30, 2014 and 2013 were not included in the computation of dilutive loss per share because the net effect would have been anti-dilutive:
			30-Jun-14			30-Jun-13
			(in thousands)
	Stock options			2,238			2,712
	Warrants			16,255			436
	Shares issuable under investor relations consulting agreement			200		__
	Shares issuable upon conversion of convertible notes payable			10,039			2,185
				28,732			5,333
	Subsequent to June 30, 2014, the number of warrants outstanding has been increased and the shares issuable upon conversion of convertible notes payable has been increased as more fully discussed in Note 14

Note_10_Related_Party_Transact

Note 10 - Related Party Transactions	6 Months Ended
	Jun. 30, 2014
Related Party Transactions [Abstract]	'
Related Party Transactions Disclosure [Text Block]	'
	10. Related Party Transactions
	As of June 30, 2014, we have entered into notes payable with related parties and a shared services agreement and letter agreements with a former related party. In addition, in June 2013, we sold common stock to a member of our board of directors. Each of these transactions is more fully described in Notes 10 and 14 to our consolidated financial statements included in our Annual Report on Form 10-K/A filed with the SEC on August 19, 2014. Certain of the related-party notes payable are also discussed in Note 5.
	Accrued Expenses
	Included in accrued expenses at June 30, 2014 and December 31, 2013 are approximately $2.0 million and $1.6 million, respectively, owed to the Company's corporate officers and directors.

Note_11_Commitments_and_Contin

Note 11 - Commitments and Contingencies	6 Months Ended
	Jun. 30, 2014
Commitments and Contingencies Disclosure [Abstract]	'
Commitments and Contingencies Disclosure [Text Block]	'
	11. Commitments and Contingencies
	We have entered into employment agreements with Mr. Scott Silverman, our Chief Executive Officer, Mr. Randolph Geissler, our President and Mr. Michael Krawitz our Chief Legal and Financial Officer. Messrs. Silverman and Geissler’s employment agreements are discussed in Note 11 and Mr. Krawitz’ employment agreement is discussed in Note 14 to our consolidated financial statements included in our Annual Report on Form10-K/A filed with the SEC on August 19, 2014.  No changes were made to these agreements during the six-months ended June 30, 2014.
	Liquidation of Signature Industries, Limited
	In March 2013, VC appointed a liquidator and initiated the formal liquidation of a U.K. subsidiary, Signature Industries Limited (“Signature”), primarily related to its outstanding liabilities. VC used £40,000 ($61,000) of the purchase price from the sale of Signature’s former division, Digital Angel Radio Communications Limited (“DARC”) to satisfy its estimated portion of Signature’s outstanding liabilities. However, one party has submitted a claim to the liquidator for approximately £244,000 (U.S. $0.4 million). This claim is associated with an outsourced manufacturing agreement related to a terminated manufacturing contract. As a result of the termination of the contract, Signature did not purchase any product under the manufacturing agreement and, accordingly, VC, in consultation with outside legal counsel, does not believe that any amount is owed per the terms of the agreement. However, this claim could result in VC having to pay an additional estimated portion of Signature’s outstanding liabilities. We expect the liquidation to be completed by the end of 2014, although it could extend beyond the expected timeframe.

Note_12_Legal_Proceedings

Note 12 - Legal Proceedings	6 Months Ended
	Jun. 30, 2014
Disclosure Text Block Supplement [Abstract]	'
Legal Matters and Contingencies [Text Block]	'
	12. Legal Proceedings
	We have been informed by the New Jersey Department of Environmental Protection that a predecessor business sold a building in 2006 for which an environmental action has been claimed. The claim is being reviewed by the Company’s outside legal counsel. We have not yet determined the impact on our financial condition or cash flows, if any.

Note_13_Supplemental_Cash_Flow

Note 13 - Supplemental Cash Flow Information	6 Months Ended
	Jun. 30, 2014
Supplemental Cash Flow Elements [Abstract]	'
Cash Flow, Supplemental Disclosures [Text Block]	'
	13. Supplemental Cash Flow Information
	We had the following non-cash operating, investing and financing activities (in thousands):
		For the Six-		For the Six-
		Months Ended		Months Ended
		30-Jun-14		30-Jun-13
	Non-cash operating activities:
	Royalty obligations now included in accrued expenses	$	100		—
	Non-cash investing and financing activities:
	Issuance of common stock in full payment of note payable and accrued interest		—		420
	Issuance of common stock in partial payment of note payable and accrued interest		70		—
	Issuances of common stock in payment of notes payable		135		—
	Conversion of promissory note under Right to Shares Agreement		191		—
	Issuance of a warrant in connection with a promissory note		66
	Cashless exercise of warrants		6,990

Note_14_Subsequent_Events

Note 14 - Subsequent Events	6 Months Ended
	Jun. 30, 2014
Subsequent Events [Abstract]	'
Subsequent Events [Text Block]	'
	14. Subsequent Events
	Consulting and Advisory Relationships and Impact on Promissory Notes and Warrants
	On July 1, 2014, July 14, 2014, and July 15, 2014, the Company entered into consulting and advisory agreements with Hanover Financial Services (“HFS”), SmallCapVoice.com, Inc. (“SCV”) and RedChip Companies Inc., respectively, relating to investor relations services.  Under the terms of the agreements, the Company issued 550,000 shares of common stock to HFS, 500,000 shares of common stock to SCV and 500,000 shares of common stock to Redchip.  The Company had previously accrued for the issuance of 200,000 shares to Redchip. Accordingly, as a result of the issuances, the Company will record, for the quarter ending September 30, 2014, charges of $77,000, $45,000, and $24,000, respectively, for the issuances of 550,000 shares to HFS 500,000 shares to SCV and 300,000 additional shares to Redchip.  Under the terms of financing transactions entered into on November 13, 2013 and on May 30, 2014, the conversion price of notes and the exercise price of warrants issued in connection with such transactions automatically adjusts following the issuance of common stock at a price per share less than the previously-applicable exercise price or conversion price.  The previously applicable price was $0.20 per share.  Because the issuance to Redchip resulted in a charge of $24,000, it is deemed to be an issuance of shares of common stock at a price per share of $0.08 per share.  Based on that, as of July 15, 2014, the exercise price and conversion price in connection with the notes issued in the November 13, 2013 financing transaction and the conversion price in connection with the notes issued in the May 30, 2014 financing transaction, reset to $0.08 per share.  Under the terms of the warrants, the aggregate exercise price must remain the same, so the number of shares of common stock subject to warrant are increased.  Accordingly, following July 15, 2014, the number of shares issuable upon conversion of the notes was 17,661,115 shares of common stock and the number shares issuable subject to warrant exercises was 38,787,016 shares at an exercise price of $0.08.
	Promissory Notes
	We have entered into the following promissory notes subsequent to June 30, 2014:
	Securities Purchase Agreement and Convertible Promissory Note Effective July 15, 2014
	Effective July 15, 2014, the funding date, the Company entered into a securities purchase agreement with an accredited investor. Pursuant to the terms of the purchase agreement, the Company issued and sold to the purchaser a convertible promissory note in the aggregate principal amount of $83,500. The note, which accrues interest at a rate of 8% per annum, will mature on April 14, 2015. The note provides the Company with several pre-payment options with varying amount due depending upon the timing of the prepayment. The note may be converted in whole or in part into the Company's common stock, at the option of the holder, at any time following 180 days after issuance and until the maturity date, unless the conversion or share issuance under the conversion would cause the holder to beneficially own in excess of 4.99% of the Company’s common stock. The conversion price shall be 61% multiplied by the market price. Market price means the average of the lowest three (3) trading prices for the Company’s common stock during the ten (10) trading day period ending on the latest complete trading day prior to the date of conversion. If and whenever the Company issues or sells, or is deemed to have issued or sold, any shares of common stock for a consideration per share less than a price equal to the conversion price in effect immediately prior to such issue or sale or deemed issuance or sale (the foregoing a “Dilutive Issuance”), then, immediately after such Dilutive Issuance, the conversion price then in effect shall be reduced to an amount equal to the new issuance price.
	The note contains certain covenants and restrictions, including, among others, that, for so long as the note is outstanding the Company will not dispose of certain assets and will maintain its listing on the over-the-counter market. Events of default under the note include, among others, failure to pay principal or interest on the note or comply with certain covenants under the note.
	Convertible Note Effective July 16, 2014
	Effective July 16, 2014, the funding date, the Company entered into a convertible note with an accredited investor in an amount up to $500,000. On July 16, 2014, the Company received $125,000 as the initial consideration under the terms of the note. The investor may pay additional consideration to the Company in such amounts and at such dates as the Investor may choose in its sole discretion. The note bears an original issue discount of 10% of the amounts funded by the investor and bears no interest for the first 90 days after each payment of consideration. If any amount funded is not paid within the 90 day period, a one-time interest payment of 12% of the amount funded becomes due. The maturity date is two years from the effective date of each payment of consideration made to the Company by the investor. The note may be converted in whole or in part into the Company's common stock, at the option of the investor. The conversion price is the lesser of $0.14 or 60% of the lowest trade price in the 25 trading days previous to the conversion. Unless otherwise agreed in writing by both parties, at no time will the investor convert any amount of the note into common stock that would result in the investor owning more than 4.99% of the Company’s common stock outstanding.
	The note provides for the Company to include the shares underlying the note in any subsequently filed registration statement to the extent that the Company files a registration statement with the SEC. Failure to do so will result in liquidated damages of 25% of the outstanding principal balance of the note, but not less than $25,000, being immediately due and payable to the Investor at its election in the form of cash payment or addition to the balance of this note.
	So long as the note is outstanding, upon any issuance by the Company or any of its subsidiaries of any security with any term more favorable to the holder of such security or with a term in favor of the holder of such security that was not similarly provided to the Investor in the note, then the Company shall notify the Investor of such additional or more favorable term and such term, at the investor’s option, shall become a part of the transaction documents with the investor.
	The note contains certain covenants and restrictions, including, among others, that, for so long as the note is outstanding, the Company shall not become delinquent in its filing requirements as a fully-reporting issuer registered with the SEC or become ineligible to use the DTC system when issuing the Company’s common stock. Events of default under the note include, among others, failure to pay principal or interest on the note or comply with certain covenants under the note.
	Securities Purchase Agreement effective August 6, 2014, 8% Convertible Redeemable Notes due July 31, 2015 and Collateralized Secured Promissory Note due July 31, 2015
	VeriTeQ Corporation (the “Company”) entered into a securities purchase agreement, (the “SPA’), dated July 31, 2014 and effective August 6, 2014, with an accredited investor (the “Buyer”). Pursuant to the terms of the SPA, the Company issued and sold to the Buyer two 8% convertible promissory notes in the amount of $75,000 each. The first note for $75,000 (the “8% Note”) was paid for by the Buyer on August 6, 2014 in cash, less transaction expenses. The second note (“8% Second Note”) was paid for by the issuance of an offsetting $75,000 secured note issued to the Company by the Buyer, (the “8% Buyer Note”) which is to be paid in cash to the Company within 8 months.
	The 8% Note matures on July 31, 2015. It may be converted in whole or in part into the Company's common stock, at the option of the holder, at any time following 180 days after issuance and until the maturity date. The conversion price shall be 61% of the average of the three lowest closing bid prices of the Company’s common stock for the fifteen prior trading days, including the day upon which the conversion notice is received by the Company. During the first 180 days that 8% Note is in effect, the Company may redeem the note by paying to the holder an amount equal to 150% of the face amount plus any accrued interest. The 8% Note may not be prepaid after the 180th day. Interest on any unpaid principal balance of 8% Note shall be paid at the rate of 8% per annum. Interest on the 8% Note shall be paid by the Company in shares of its common stock, referred to as Interest Shares. The holder may, at any time, send in a notice of conversion to the Company for Interest Shares based on the formula provided above for principal conversions.
	The 8% Second Note matures on July 31, 2015. The holder of the 8% Second Note is entitled, at its option, after the expiration of the requisite Rule 144 holding period and after full cash payment of the 8% Buyer Note, to convert all or any amount of the principal face amount of the 8% Second Note then outstanding into shares of the Company's common stock without restrictive legend of any nature, at a conversion price for each share of the Company’s common stock equal to 61% of the average of the three lowest closing bid prices of the Company’s common stock for the fifteen prior trading days, including the day upon which the conversion notice is received by the Company. The 8% Second Note may not be prepaid, except in certain circumstances described therein. Interest on any unpaid principal balance of the 8% Second Note shall be paid by the Company in Interest Shares. The holder may, at any time, send in a notice of conversion to the Company for Interest Shares based on the formula provided above for principal conversions.
	The 8% Note and the 8% Second Note contain certain covenants and restrictions, including, among others, that, for so long as the notes are outstanding the Company will not dispose of certain assets and will maintain its listing on the over-the-counter market. Events of default under the note include, among others, failure to pay principal or interest on the note or comply with certain covenants under the note.
	As discussed above, the Buyer issued to the Company, the 8% Buyer Note, also referred to as the Collateralized Secured Promissory Back End Note, in the amount of $75,000, which matures no later than March 31, 2015, unless the Company does not meet the “current information requirements” required under Rule 144 of the Securities Act of 1933, as amended, in which case the Buyer may declare the 8% Second Note to be in default (as defined in that note) and cross cancel its payment obligations under the 8% Buyer Note against the Company’s payment obligations under the 8% Second Note. The 8% Buyer Note shall bear simple interest at the rate of 8%. The Buyer may, at its option, prepay the 8% Buyer Note at any time. The 8% Buyer Note may not be assigned by the Company, except by operation of law..
	Securities Purchase Agreement effective August 4, 2014, 12% Convertible Redeemable Notes due August 4, 2015 and Collateralized Secured Promissory Note due August 4, 2015
	The Company entered into a securities purchase agreement, (the “Purchase Agreement’), effective August 4, 2014, with an accredited investor (the “Lender”). Pursuant to the terms of the Purchase Agreement, the Company issued and sold to the Lender two 12% convertible promissory notes in the amount of $50,000 each. The first note for $50,000 (the “12% Note”) was paid for by the Lender on August 4, 2014 in cash, less transaction expenses. The second note (the “12% Second Note”) was initially paid for by the issuance of an offsetting $50,000 secured note issued to the Company by the Lender, (the “12% Lender Note”), which is to be paid in cash to the Company within 8 months.
	The 8% Note matures on August 4, 2015. It may be converted in whole or in part into the Company's common stock, at the option of the holder, at any time following 180 days after issuance and until the maturity date. The conversion price shall be 61% of the average of the three lowest closing bid prices of the Company’s common stock for the twenty prior trading days, including the day upon which the conversion notice is received by the Company. During the first 180 days the 12% Note is in effect, the Company may redeem the note by paying to the holder an amount equal to 150% of the face amount plus any accrued interest. The 12% Note may not be prepaid after the 180th day. Interest on any unpaid principal balance of 12% Note shall be paid at the rate of 12% per annum. Interest on the 12% Note shall be paid by the Company in shares of its common stock, referred to as Interest Shares. The holder may, at any time, send in a notice of conversion to the Company for Interest Shares based on the formula provided above for principal conversions.
	The 12% Second Note matures on August 4, 2015. The holder of the 12% Second Note is entitled, at its option, after the expiration of the requisite Rule 144 holding period and after full cash payment of the 12% Lender Note, to convert all or any amount of the principal face amount of the 12% Second Note then outstanding into shares of the Company's common stock without restrictive legend of any nature, at a conversion price for each share of the Company’s common stock equal to 61% of the average of the three lowest closing bid prices of the Company’s common stock for the twenty prior trading days, including the day upon which the conversion notice is received by the Company. The 12% Second Note may not be prepaid, except in certain circumstances described therein. Interest on any unpaid principal balance of the 12% Second Note shall be paid by the Company in Interest Shares. The holder may, at any time, send in a notice of conversion to the Company for Interest Shares based on the formula provided above for principal conversions.
	The 12% Note and the 12% Second Note contain certain covenants and restrictions, including, among others, that, for so long as the notes are outstanding the Company will not dispose of certain assets and will maintain its listing on the over-the-counter market. Events of default under the note include, among others, failure to pay principal or interest on the note or comply with certain covenants under the note.
	As discussed above, the Lender issued to the Company, the 12% Lender Note, also referred to as the Collateralized Secured Promissory Back End Note, in the amount of $50,000, which matures no later than April 4, 2015, unless the Company does not meet the “current information requirements” required under Rule 144 of the Securities Act of 1933, as amended, in which case the Lender may declare the 12% Second Note to be in default (as defined in that note) and cross cancel its payment obligations under the 12% Lender Note against the Company’s payment obligations under the 12% Second Note. The 12% Lender Note shall bear simple interest at the rate of 12%. The Lender may, at its option, prepay the 12% Lender Note at any time. The 12% Lender Note may not be assigned by the Company, except by operation of law.
	Impact of Promissory Notes and Warrants of Variable Priced Promissory Notes
	Under the terms of a financing from November 13, 2013 and on May 30, 2014, the holders of the notes and warrants issued in connection with such transactions, following the issuance of any security with a variable price conversion feature, may substitute the variable price formula for their exercise or conversion prices.  The promissory notes described above contain a variable price conversion feature. As a result, the holder of a warrant issued on November 13, 2013 may substitute a formula resulting in a lower price.  Moreover, the warrants provide that the holder of the warrant has the right to invest the same aggregate amount.  Accordingly, whenever a lower price applies, a larger number of shares may be purchased.   The exact number of shares that may be issued varies depending on the stock price at the time of exercise or conversion.  On August 12, 2014, if all of the outstanding warrants issued in connection with the November 13, 2013 financing had been exercised, the alternative price formulation could have resulted in an increase in the number of warrants from 38,787,016 at an exercise price of $0.08 per share to warrants to acquire 144,851,212 shares of the Company's common stock at an exercise price of $0.021 per share.  The warrant holders have the right to effect a cashless exercise by accepting fewer shares and not tendering cash.  On August 12, 2014, $1,413,000 principal amount of notes issued in connection with the November 13, 2013 and May 30, 2014 financings was outstanding.  If all such outstanding notes had been converted on such date, it would have resulted in an issuance of approximately 66,900,000 shares and the elimination of the liability for the Company.  Because the variable price formula changes with the value of the common stock, the number of shares subject to warrant and the number of shares into which the notes are convertible varies.

Accounting_Policies_by_Policy_

Accounting Policies, by Policy (Policies)	6 Months Ended
	Jun. 30, 2014
Accounting Policies [Abstract]	'
Consolidation, Policy [Policy Text Block]	'
	Principles of Consolidation
	The financial statements include our accounts and the accounts of our subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.
Reclassification, Policy [Policy Text Block]	'
	Classification of Expenses
	For comparative purposes, we have reclassified certain expenses related to the development of our products from selling, general and administrative expenses to development expenses in the historical financial statement presented herein.
Use of Estimates, Policy [Policy Text Block]	'
	Use of Estimates
	The preparation of financial statements in conformity with generally accepted accounting principles (“GAAP”) in the United States of America (“U.S.”) requires management to make certain estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Although these estimates are based on the knowledge of current events and actions we may undertake in the future, they may ultimately differ from actual results. Included in these estimates are assumptions used in determining the lives of long-lived assets, in Black-Scholes-Merton (“BSM”) valuation models in estimating the fair value of stock-based compensation and warrants, promissory notes with an embedded convertible option and royalty obligations and in determining valuation allowances for intangible assets, deferred tax assets, among others.
Concentration Risk, Credit Risk, Policy [Policy Text Block]	'
	Concentration of Credit Risk
	We maintained our domestic cash in two financial institutions during the period ended June 30, 2014. Balances were insured up to Federal Deposit Insurance Corporation limits of $250,000 per institution. At times, cash balances may exceed the federally insured limits.
Other Current Assets [Policy Text Block]	'
	Other Current Assets
	Other current assets consist primarily of deferred financing costs of approximately $20,000 at June 30, 2014 and prepaid insurance of approximately $28,000 and $74,000 at June 30, 2014 and December 31, 2013, respectively. No other items included in other current assets at June 30, 2014 and December 31, 2013 exceeded 5% of total current assets, respectively.
Inventory, Policy [Policy Text Block]	'
	Inventory
	Inventory consisted of purchased finished goods at June 30, 2014 and December 31, 2013. Inventory is valued at the lower of the value using the first-in, first-out (“FIFO”) cost method, or market.
Property, Plant and Equipment, Policy [Policy Text Block]	'
	Property and Equipment
	Property and equipment, consisting primarily of computer equipment, and are stated at cost less accumulated depreciation. Depreciation expense is computed using the straight-line method over the estimated useful life of the related assets (generally three years for computer equipment and 10 years for other equipment). Depreciation expense for the three-months ended June 30, 2014 and 2013 was approximately $1 thousand and nil, respectively. Depreciation expense for the six-months ended June 30, 2014 and 2013 was approximately $1 thousand and nil, respectively.
Goodwill and Intangible Assets, Policy [Policy Text Block]	'
	Intangible Assets
	We account for intangible assets in accordance with the Intangibles — Goodwill and Other Topic of the Codification. Intangible assets deemed to have an indefinite life, such as goodwill, are reviewed at least annually for impairment. Intangible assets with finite lives are amortized over their estimated useful lives. We do not have any intangible assets with indefinite lives.
	We have intangible assets consisting of technology, customer relationship and trademarks, which are more fully discussed in Note 3. These intangible assets are amortized over their expected economic lives ranging from 7 to 14 years. The lives were determined based upon the expected use of the asset, the ability to extend or renew patents, trademarks and other contractual provisions associated with the asset, the stability of the industry, expected changes in and replacement value of distribution networks and other factors deemed appropriate. We continually evaluate whether events or circumstances have occurred that indicate the remaining estimated useful lives of our definite-lived intangible assets warrant revision or that the remaining balance of such assets may not be recoverable. We use an estimate of the related undiscounted cash flows over the remaining life of the asset in measuring whether the asset is recoverable. We believe that no impairment of our intangible assets existed as of June 30, 2014.
Revenue Recognition, Policy [Policy Text Block]	'
	Revenue Recognition
	Product revenue is recognized at the time product is shipped and title has transferred, provided that a purchase order has been received or a contract has been executed, there are no uncertainties regarding customer acceptance, the sales price is fixed and determinable and collectability is deemed probable. If uncertainties regarding customer acceptance exist, we intend to recognize the revenue when such uncertainties are resolved. There are no significant post-contract support obligations at the time of revenue recognition. Our accounting policy regarding vendor and post contract support obligations is based on the terms of the customers’ contracts and is billable upon occurrence of the post-sale support. Currently, there are no multiple element arrangements in connection with our product sales. Cost of products sold is recorded as the related revenue is recognized. We offer a warranty on our products and record a liability for product warranties at the time it is probable that a warranty liability has been incurred and the amount of loss can reasonably be estimated. To date, we have not incurred a warranty liability on products we have sold. It is our policy to approve all customer returns before issuing credit to the customer.
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	'
	Stock-Based Compensation
	At June 30, 2014, we had five stock-based employee compensation plans which are more fully described in Note 7 to our consolidated financial statements included in our Annual Report on Form 10-K filed with the SEC on April 15, 2014. In accordance with the Compensation – Stock Compensation Topic of the Codification, awards granted are valued at fair value and compensation cost is recognized on a straight line basis over the service period of each award. On June 18, 2014, our majority stockholders approved the 2014 Stock Incentive Plan, which is more fully discussed in Note 7.
Income Tax, Policy [Policy Text Block]	'
	Income Taxes
	We recognize deferred tax liabilities and assets for the expected future tax consequences of events that have been included in the financial statement or tax returns. Under this method, deferred tax liabilities and assets are determined based on the difference between financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Temporary differences between taxable income reported for financial reporting purposes and income tax purposes consist primarily of timing differences such as amortization of intangible assets, deferred officers' compensation and stock-based compensation. A valuation allowance is provided against net deferred tax assets where we determine realization is not currently judged to be more likely than not. We recognize and measure uncertain tax positions through a two-step process. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount which is more than 50% likely of being realized upon ultimate settlement. We consider many factors when evaluating and estimating tax positions and tax benefits, which may require periodic adjustments and which may not accurately anticipate actual outcomes. Accordingly, we report a liability for unrecognized tax benefits resulting from the uncertain tax positions taken or expected to be taken in a tax return and recognize interest and penalties, if any, related to uncertain tax positions in income tax expense.
Earnings Per Share, Policy [Policy Text Block]	'
	Loss Per Common Share and Common Share Equivalent
	Basic and diluted loss per common share has been computed by dividing the loss by the weighted average number of common shares outstanding. Since we have incurred losses attributable to common stockholders, diluted loss per common share has not been computed by giving effect to all potentially dilutive common shares that were outstanding during the period., since to do so would have been anti-dilutive. See Note 9 for the computation of basic and diluted loss per share.
New Accounting Pronouncements, Policy [Policy Text Block]	'
	Impact of Recently Issued Accounting Standards
	From time to time, the Financial Accounting Standards Board (“FASB”) or other standards setting bodies will issue new accounting pronouncements. Updates to the FASB Accounting Standards Codification (“ASC” or “Codification”) are communicated through issuance of an Accounting Standards Update (“ASU”).
	In June 2014, the FASB issued ASU Codification Development Stage Entities (Topic 915), Elimination of Certain Financial Reporting Requirements, Including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation. The amendments related to the elimination of inception-to date information and other remaining disclosure requirements of Topic 915, which should be applied retrospectively and are effective for annual reporting periods beginning after December 15, 2014 and interim periods therein. The amendments also clarify that the guidance in Topic 275, Risks and Uncertainties, is applicable to entities that have not commenced planned principal operations. The amendments regarding Topic 275 and the sufficiency-of-equity-at-risk criterion for development stage entities of Topic 810 shall be applied prospectively. The adoption of these amendments will eliminate the inception--to–date information that is currently presented in the Company’s financial statements and may result in enhanced disclosures regarding risks and uncertainties applicable to the Company’s business.
	In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update No. 2014-09,”Revenue from Contracts with Customers (Topic 606),” (“ASU 2014-09”). ASU 2014-09 outlines a new, single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. This new revenue recognition model provides a five-step analysis in determining when and how revenue is recognized. The new model will require revenue recognition to depict the transfer of promised goods or services to customers in an amount that reflects the consideration a company expects to receive in exchange for those goods or services. ASU 2014-09 is effective for public entities for annual reporting periods beginning after December 15, 2016 and interim periods within those periods. Early adoption is not permitted. Companies may use either a full retrospective or a modified retrospective approach to adopt ASU 2014-09. The Company is currently assessing the impact that adopting this new accounting guidance will have on its consolidated financial statements and footnote disclosures.

Note_1_Organization_and_Summar1

Note 1 - Organization and Summary of Significant Accounting Policies (Tables)	3 Months Ended										6 Months Ended
	Jun. 30, 2014										Jun. 30, 2014
Accounting Policies [Abstract]	'										'
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	'										'
		For the Three-Months			Correction			For the Three-Months				Three-Months Ended						Six-Months Ended
		Ended						Ended				June 30,						June 30,
		June 30,						June 30,				2014			2013			2014			2013
		2014 As Previously						2014 As Restated				As Restated						As Restated
		Reported									Numerator for basic and diluted loss per share:
	Net loss per common share — basic and diluted	$	(0.28	)	$	(0.12	)	$	(0.40	)	Loss from continuing operations	$	(5,558	)	$	(1,542	)	$	(933	)	$	(2,852	)
	Weighted average number of common shares outstanding – basic and diluted		19,913			(6,024	)		13,889
		For the Six-Months Ended			Correction			For the Six-Months Ended			Denominator for basic and diluted loss per share:
		30-Jun-14						30-Jun-14			Basic and diluted weighted-average shares outstanding (1)		13,889			9,042			11,756			8,941
		As Previously Reported						As Restated
	Net loss per common share -- basic and diluted	$	(0.06	)	$	(0.02	)	$	(0.08	)	Loss per share— basic and diluted:
	Weighted average number of common shares outstanding – basic and diluted		14,758			(3,002	)		11,756		Total — basic and diluted	$	(0.40	)	$	(0.17	)	$	(0.08	)	$	(0.32	)

Note_2_Acquisition_Tables

Note 2 - Acquisition (Tables)	6 Months Ended
	Jun. 30, 2014
Disclosure Text Block Supplement [Abstract]	'
Schedule of Business Acquisitions, by Acquisition [Table Text Block]	'
	Acquisition	Dates		Acquisition		Intangible		Description of Assets
		Acquired		Price		Assets
						Acquired
	(in thousands)
	VeriTeQ Corporation	7/8/13		$	935	$	—	Cash, marketable securities and receivables, among others
Business Acquisition, Pro Forma Information [Table Text Block]	'
	(In thousands, except per share amounts)		Six-Months
			Ended June 30,
			2013
	Net operating revenue		$	—
	Loss from continuing operations		$	(3,208	)
	Loss per common share from continuing operations– basic and diluted		$	(0.35	)

Note_3_Intangible_Assets_Table

Note 3 - Intangible Assets (Tables)	6 Months Ended
	Jun. 30, 2014
Disclosure Text Block [Abstract]	'
Schedule of Intangible Assets and Goodwill [Table Text Block]	'
		June 30,		December 31,		Lives
		2014		2013		(in years)
		(in thousands)		(in thousands)
	Technology, net of accumulated amortization of $873 and $627	$	5,998	$	6,244		14
	Customer relationship, net of accumulated amortization of $176 and $141		324		359		7
	Trademarks, net of accumulated amortization of $51 and $35		399		415		14
		$	6,721	$	7,018

Note_4_Accrued_Expenses_Tables

Note 4 - Accrued Expenses (Tables)	6 Months Ended
	Jun. 30, 2014
Other Liabilities and Financial Instruments Subject to Mandatory Redemption [Abstract]	'
Schedule of Accrued Liabilities [Table Text Block]	'
		June 30,		December 31,
		2014		2013
		(in thousands)
	Accrued payroll and payroll related	$	2,315	$	1,734
	Accrued legal		454		445
	Accrued other expenses		811		539
	Total accrued expenses	$	3,580	$	2,718

Note_5_Notes_Payable_and_Restr1

Note 5 - Notes Payable and Restricted Cash (Tables)	6 Months Ended
	Jun. 30, 2014
Debt Disclosure [Abstract]	'
Schedule of Debt [Table Text Block]	'
		June 30,			December 31,
		2014			2013
		(in thousands)
	Note originally with PSID for $200 dated January 11, 2012, bore interest at 5% per annum, was originally payable in monthly instalments beginning January 11, 2013 through December 11, 2014. Note was amended in July 2013 to allow for conversion into common stock and extend payment terms. After the note was partially converted into common stock in October 2013, PSID assigned the note to a group of lenders in November 2013. One of the lenders converted $60 of the note and $10 of accrued interest into 47 shares of common stock in February 2014. The Company issued warrants to acquire 300 shares of its common stock to PSID in connection with a letter agreement entered into in November 2013, that were reset on May 30, 2014 to warrants to acquire 4,260 shares at an exercise price of $0.20 per share. (2)(3)	$	115		$	175
	Demand note for $80 issued October 11, 2013 to our CEO, bears interest at 5% per annum repaid in November 2013, February and April 2014(1)		—			30
	Demand note for $30 issued October 29, 2013 to our CEO, bears interest at 5% per annum, partially repaid in April 2014(1)		26			30
	Senior Secured Convertible Notes issued November 13, 2013 for $1,817, of which $726 was repaid or converted in June 2014, net of discount of $400 and $1,585, to group of institutional investors, are convertible into shares of common stock at $0.20 per share and mature November 13, 2014. Notes were issued with Warrants to acquire 2,644 shares of common stock with an exercise price of $2.84 per share that were reset on May 30, 2014 to warrants to acquire 37,551 shares of common stock with an exercise price of $0.20 per share of which 11,254 were outstanding on June 30, 2014. (2)(4)		691			232
	Demand note for $60 issued January 8, 2014 to Michael Krawitz, our CFO, bears interest at 5% per annum (1)		60			—
	Demand note for $60 issued January 16, 2014 to our CEO, bears interest at 5% per annum (1)		60			—
	Demand note for $40 issued January 16, 2014 to our President, bears interest at 5% per annum (1)		40			—
	Note for $175 issued on February 4, 2014 to Corbin Properties LLC, bears interest at 10% per annum, due February 4, 2015		175			—
	Demand note for $25 issued March 4, 2014 to a Director, bears interest at 5% per annum (1)		25			—
	Note for $25 issued March 5, 2014 to Deephaven Enterprises, Inc., net of discount of $22, bears interest at 9% per annum, due March 5, 2015. Effective May 30, 2014, the note became convertible into shares of common stock at a price of $0.35 per share.		3			—
	Note for $25 issued on March 6, 2014, to James Rybicki Trust, net of discount of $22, bears interest at 9% per annum, due March 6, 2015. Effective May 30, 2014, the note became convertible into shares of common stock at a price of $0.35 per share.		3			—
	Note for $25 issued on March 10, 2014, to William Caragol, net of discount of $25, bears interest at the rate of 9% per annum, due March 10, 2015. Effective May 30, 2014, the note became convertible into shares of common stock at a price equal to 60% of the lowest closing bid price over the 10-trading days immediately preceding a conversion notice.		—			—
	Note for $61 issued on March 20, 2014 to Deephaven Enterprises, Inc., net of discount of $43, bears interest at the rate of 9% per annum, due March 20, 2015. Effective May 30, 2014, existing outstanding common stock warrants held by the holder became exercisable at $0.35 per share and an additional 300 warrants to acquire shares of the Company’s common stock with an exercise price of $0.35 per share were granted. (2)		18			—
	Note for $25 issued April 16, 2014 to William Caragol, net of discount of $23, bears interest at 9% per annum, due April 16, 2015. Effective May 30, 2014, the note became convertible into shares of common stock at a price of $0.35 per share if conversion is elected by the holder or 60% of the lowest closing bid price over the 10-trading days immediately preceding a conversion notice if elected by the Company.		2			—
	Note for $30 issued on April 16, 2014, to Ned Siegel, net of discount of $27, bears interest at 9% per annum, due April 16, 2015. Effective May 30, 2014, the note became convertible into shares of common stock at a price of $0.35 per share. (1)		3			—
	Note for $20 issued on May 1, 2014, to Ned Siegel, net of discount of $18, bears interest at the rate of 9% per annum, due March 10, 2015. Effective May 30, 2014, the note became convertible into shares of common stock at a price of $0.35 per share. The note was issued with 100 warrants to acquire shares of the Company’s common stock with an exercise price of $0.35 per share. (1) (2).		2			—
	Senior Convertible Note for $222 issued May 30, 2014 to an Investor, net of discount of $203, convertible into shares of common stock at $0.20 per share and matures May 30, 2015. Note was issued with an original issue discount of $22 in lieu of interest. (4)		19			—
	Senior Convertible Note for $100 issued on May 30, 2014 to an Investor, net of discount of $92, convertible into shares of common stock at $0.20 per share, bears no interest, due May 30, 2015. (4)		8			—
	Total notes payable		1,250			467
	Less: Current maturities		(1,250	)		(467	)
	Note payable long-term	$	—		$	—
	Subordinated Convertible Note Payable elected at fair value:
	Non-interest bearing subordinated convertible note payable with a principal amount of $3,300 dated December 3, 2012. Note is convertible into common stock equal to 1/3 of the shares beneficially held by the CEO on the date of conversion. Note was amended in July 2013 to extend the maturity date to June 2015. The note was recorded at its fair value and will be revalued at each reporting period with changes in the fair value recorded as other expense/income.	$	2,137		$	4,925

Note_6_Financial_Instruments_T

Note 6 - Financial Instruments (Tables)	6 Months Ended
	Jun. 30, 2014
Disclosure Text Block Supplement [Abstract]	'
Fair Value, by Balance Sheet Grouping [Table Text Block]	'
		30-Jun-14									31-Dec-13
		Level 1			Level 2			Level 3			Level 1			Level 2		Level 3
	Liabilities:
	Subordinated convertible note with an embedded conversion option	$	—		$	—		$	2,137		$	—		$	—	$	4,925
	Embedded conversion option of the convertible notes	$	—		$	—		$	125		$	—		$	—	$	3,124
	Warrant liabilities	$	—		$	—		$	1,962		$	—		$	—	$	6,114
	Royalty obligations	$	—		$	—		$	4,000		$	—		$	—	$	4,000
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	'
		Subordinated			Embedded Conversion Option of Convertible Notes			Warrant			Estimated
		Note with						Liabilities			Royalty
		Convertible									Obligations
		Option
	Balance at December 31, 2013	$	4,925		$	3,124		$	6,114		$	4,000
	Increase due to embedded conversion option for May 30, 2014 convertible notes payable		—			629			—			—
	Change in fair value		(2,788	)		(3,628	)		2,838			—
	Exercise of warrants under Right to Shares Agreements		—						(6,990	)		—
	Balance at June 30, 2014	$	2,137	(1)	$	125		$	1,962		$	4,000	-2

Note_7_Stockholders_Deficit_Ta

Note 7 - Stockholders' Deficit (Tables)	6 Months Ended
	Jun. 30, 2014
Stockholders' Equity Note [Abstract]	'
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	'
	Series/ Issue Date	Warrants			Additional			Exercised			Balance				Exercise		Exercisable
		Issued/As			Warrants						June 30,				Price		Period
		Reset			under						2014						(years)
					Cashless
					Exercise
					Provisions
	Series A /June 2012		95			—			(95	)		—			$	0.37		3
	Series B / September 2012		40			—			—			40			$	1.57		3
	Series C / October 2012		20			—			—			20			$	1.57		3
	Series C / October 2012, reset May 2014		20			—			—			20			$	0.35		3
	Series D / December 2012		14			—			—			14			$	1.57		5
	Series E /December 2012		29			—			—			29			$	1.57		5
	Series F / March 2013		40			—			—			40			$	1.57		3
	Series G / April 2013		47		−−				—			47			$	1.31		3
	Series G / April 2013, reset May 2014		48		−−				—			48			$	0.35		3
	Series H / June 2013		63		−−				—			63			$	1.57		3
	Series H/ June 2013, reset May 2014		20		−−				—			20			$	0.35		3
	Series VT a/ November 2013, as reset May 2014		37,551			2,966			(29,263	)		11,254			$	0.2		5
	Series VT b/ November 2013, as reset May 2014		4,260			—			—			4,260			$	0.2		5
	Series I/ May 2014		300			—			—			300			$	0.35		3
	Series J/ May 2014		100			—			—			100			$	0.35		2
			42,647			2,966			(29,358	)		16,255
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value [Table Text Block]	'
	Dates Warrants Issued/Reset	Dividend			Volatility			Expected			Risk-Free			Date of the
		Yield						Lives (Yrs.)			Rate			Assumptions
	Jun-12		0	%		126	%		3			0.34	%	1-Jun-12
	Sep-12		0	%		126	%		3			0.35	%	25-Sep-12
	Oct-12		0	%		126	%		3			0.35	%	12-Oct-12
	October 2012, reset May 2014		0	%		223	%		1.37			0.1	%	30-May-14
	Dec-12		0	%		126	%		5			0.72	%	31-Dec-12
	Mar-13		0	%		126	%		3			0.38	%	18-Mar-13
	Apr-13		0	%		126	%		3			0.34	%	10-Apr-13
	April 2013, reset May 2014		0	%		210	%		1.87			0.37	%	30-May-14
	Jun-13		0	%		126	%		3			0.52	%	1-Jun-13
	June 2013, reset May 2014		0	%		215	%		2.01			0.37	%	30-May-14
	November 2013, reset May 2014		0	%		163	%		4.46			1.54	%	30-May-14
	May 2014 (Series I)		0	%		192.26	%		2.8			0.79	%	30-May-14
	May 2014 (Series J)		0	%		214.78	%		2			0.39	%	30-May-14
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	'
		Stock			Weighted			Weighted			Aggregate
		Options			Average			Average			Intrinsic
					Exercise			Contractual			Value
					Price			Term
								(years)
	Outstanding at January 1, 2014		2,628		$	9.01
	Granted		—			—
	Exercised		(382	)		0.05
	Forfeited or expired		(8	)		659.87
	Outstanding at June 30, 2014		2,238			8.02			4.65		$	77,000	*
	Vested or expected to vest at June 30, 2014		2,238			8.02			4.65		$	77,000	*
	Shares available on June 30, 2014 for options that may be granted		2,508

Note_9_Loss_Per_Share_Tables

Note 9 - Loss Per Share (Tables)	3 Months Ended										6 Months Ended
	Jun. 30, 2014										Jun. 30, 2014
Earnings Per Share [Abstract]	'										'
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	'										'
		For the Three-Months			Correction			For the Three-Months				Three-Months Ended						Six-Months Ended
		Ended						Ended				June 30,						June 30,
		June 30,						June 30,				2014			2013			2014			2013
		2014 As Previously						2014 As Restated				As Restated						As Restated
		Reported									Numerator for basic and diluted loss per share:
	Net loss per common share — basic and diluted	$	(0.28	)	$	(0.12	)	$	(0.40	)	Loss from continuing operations	$	(5,558	)	$	(1,542	)	$	(933	)	$	(2,852	)
	Weighted average number of common shares outstanding – basic and diluted		19,913			(6,024	)		13,889
		For the Six-Months Ended			Correction			For the Six-Months Ended			Denominator for basic and diluted loss per share:
		30-Jun-14						30-Jun-14			Basic and diluted weighted-average shares outstanding (1)		13,889			9,042			11,756			8,941
		As Previously Reported						As Restated
	Net loss per common share -- basic and diluted	$	(0.06	)	$	(0.02	)	$	(0.08	)	Loss per share— basic and diluted:
	Weighted average number of common shares outstanding – basic and diluted		14,758			(3,002	)		11,756		Total — basic and diluted	$	(0.40	)	$	(0.17	)	$	(0.08	)	$	(0.32	)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	'										'
												30-Jun-14			30-Jun-13
												(in thousands)
											Stock options		2,238			2,712
											Warrants		16,255			436
											Shares issuable under investor relations consulting agreement		200		__
											Shares issuable upon conversion of convertible notes payable		10,039			2,185
													28,732			5,333

Note_13_Supplemental_Cash_Flow1

Note 13 - Supplemental Cash Flow Information (Tables)	6 Months Ended
	Jun. 30, 2014
Supplemental Cash Flow Elements [Abstract]	'
Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]	'
		For the Six-		For the Six-
		Months Ended		Months Ended
		30-Jun-14		30-Jun-13
	Non-cash operating activities:
	Royalty obligations now included in accrued expenses	$	100		—
	Non-cash investing and financing activities:
	Issuance of common stock in full payment of note payable and accrued interest		—		420
	Issuance of common stock in partial payment of note payable and accrued interest		70		—
	Issuances of common stock in payment of notes payable		135		—
	Conversion of promissory note under Right to Shares Agreement		191		—
	Issuance of a warrant in connection with a promissory note		66
	Cashless exercise of warrants		6,990

Note_1_Organization_and_Summar2

Note 1 - Organization and Summary of Significant Accounting Policies (Details)

0 Months Ended

1 Months Ended

3 Months Ended

6 Months Ended

0 Months Ended

1 Months Ended

6 Months Ended

1 Months Ended

1 Months Ended

0 Months Ended

1 Months Ended

0 Months Ended

0 Months Ended

0 Months Ended

6 Months Ended

Jul. 12, 2013

Jan. 30, 2014

Jan. 30, 2014

Jun. 30, 2014

Jun. 30, 2014

Jun. 18, 2014

Jun. 17, 2014

Mar. 31, 2014

Dec. 31, 2013

Nov. 13, 2013

Oct. 18, 2013

Jul. 08, 2013

Oct. 18, 2013

Jun. 30, 2014

Oct. 17, 2013

Jul. 12, 2013

Jun. 30, 2014

Jun. 30, 2014

30-May-14

Nov. 13, 2013

Jun. 18, 2014

Jun. 18, 2014

Aug. 15, 2014

Jun. 17, 2014

Jun. 27, 2014

Jun. 30, 2014

Aug. 15, 2014

Jun. 25, 2014

Jun. 30, 2014

Jun. 26, 2014

Jul. 12, 2013

Jul. 12, 2013

Jul. 16, 2014

Jul. 15, 2014

Jul. 15, 2014

Aug. 12, 2014

Jul. 15, 2014

Jul. 12, 2013

Jun. 18, 2014

30-May-14

Nov. 13, 2013

Jun. 30, 2014

Jun. 30, 2014

USD ($)

USD ($)

GBP (£)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

Series B Preferred Stock [Member]

Series C Preferred Stock [Member]

Series C Preferred Stock [Member]

Series C Preferred Stock [Member]

Series C Preferred Stock [Member]

Computer Equipment [Member]

Non Computer Equipment [Member]

Financing Arrangement, May 30, 2014 [Member]

Financing Arrangement, May 30, 2014 [Member]

Right To Shares Agreement - June 18, 2014 [Member]

Right To Shares Agreement - June 18, 2014 [Member]

Right To Shares Agreement - June 18, 2014 [Member]

Right To Shares Agreement - June 18, 2014 [Member]

Right To Shares Agreement - June 18, 2014 [Member]

Right To Shares Agreement - June 18, 2014 [Member]

Rights To Shares Agreement - June 24, 2014 [Member]

Rights To Shares Agreement - June 24, 2014 [Member]

Rights To Shares Agreement - June 24, 2014 [Member]

Rights To Shares Agreement - June 24, 2014 [Member]

Series B Preferred Stock Converted to Series C Convertible Preferred Stock [Member]

Series C Preferred Stock Convertible Into Twenty Shares of VC's Common Stock [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

VC Acquisition [Member]

2014 Stock Incentive Plan [Member]

Investors [Member]

Investors [Member]

Minimum [Member]

Maximum [Member]

Issued and Outstanding Common Stock Exchanged for Series B Convertible Preferred Stock [Member]

Subsequent Event [Member]

USD ($)

Investors [Member]

Investors [Member]

Warrant Holder Original Entitlement Amount [Member]

Warrant Satisfaction Settlement [Member]

Subsequent Event [Member]

Subsequent Event [Member]

USD ($)

USD ($)

Investors [Member]

Investors [Member]

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

Note 1 - Organization and Summary of Significant Accounting Policies (Details) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Convertible Notes Payable (in Dollars)

'

'

'

'

'

'

'

'

'

$1,816,667

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$400,000

'

$190,667

'

'

$500,000

$83,500

'

$1,413,000

'

'

'

$300,000

$1,816,667

'

'

Debt Instrument, Convertible, Conversion Price (in Dollars per share)

'

'

'

$0.20

$0.20

'

'

'

'

$0.75

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0.14

'

'

'

$0.08

'

'

$0.20

$0.75

'

'

Understatement of Derivative Liability (in Dollars)

'

'

'

'

'

'

'

2,100,000

3,100,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Development Stage Enterprise, Deficit Accumulated During Development Stage (in Dollars)

'

'

'

20,757,000

20,757,000

'

'

'

19,824,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Conversion of Stock, Shares Converted

'

'

'

'

'

'

'

'

'

'

'

4,107,592

8,215,184

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred Stock, Conversion Basis

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'410,759

'

'

'

'

'

'

'

'

'

'

'

'

Preferred Stock, Par or Stated Value Per Share (in Dollars per share)

'

'

'

$10

$10

$0.01

$10

'

$10

'

'

'

'

'

'

$10

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Convertible Preferred Stock, Shares Issued upon Conversion

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

20

'

'

'

'

'

'

'

'

'

'

'

Common Stock, Par or Stated Value Per Share (in Dollars per share)

$0.01

'

'

$0.01

$0.01

'

'

'

$0.01

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Sale of Stock, Percentage of Ownership after Transaction

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

91.00%

'

'

'

'

'

Exchange Ratio

0.19083

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred Stock, Shares Authorized

'

'

'

5,000,000

5,000,000

'

'

'

5,000,000

'

'

'

'

500,000

500,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred Stock, Shares Issued

'

'

'

0

0

'

'

'

0

'

'

'

'

'

410,759

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Issued Outstanding Shares Following Reverse Merger Percentage

'

'

'

'

'

'

'

'

'

'

88.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stockholders' Equity Note, Stock Split, Conversion Ratio

30

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common Stock, Shares, Outstanding

'

'

'

41,480,000

41,480,000

'

'

'

9,459,000

'

9,302,674

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common Stock, Shares Authorized

'

'

'

50,000,000

50,000,000

500,000,000

50,000,000

'

50,000,000

'

50,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common Stock, Capital Shares Reserved for Future Issuance

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

495,000

'

'

10,530,289

9,448,659

'

18,566,659

'

'

'

'

'

'

'

'

'

50,000,000

'

'

'

'

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0.08

$0.08

'

'

$0.20

$2.84

'

'

Class of Warrant or Right, Number of Securities Called by Warrants or Rights

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

41,811,114

2,944,444

15,199,410

11,500,000

'

'

'

'

'

17,763,325

'

18,716,659

'

'

'

'

'

38,787,016

38,787,016

'

'

'

2,422,222

'

'

Stock Issued During Period, Shares, Conversion of Units

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

495,711

474,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Issued During Period, Shares, New Issues

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

10,035,289

'

'

'

9,118,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Class Of Warrant Or Right, Cash The Holder Is Entitled To, Upon Redemption (in Dollars)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

400,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Conversion, Original Debt, Amount (in Dollars)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

190,667

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Conversion, Converted Instrument, Shares Issued

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

953,334

150,000

'

'

'

'

'

17,661,115

'

'

'

'

'

'

'

'

Proceeds from Divestiture of Businesses

'

100,000

62,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Gain (Loss) on Disposition of Business (in Dollars)

'

'

'

'

-56,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of Financial Institutions

'

'

'

2

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Cash, FDIC Insured Amount (in Dollars)

'

'

'

250,000

250,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Deferred Finance Costs, Gross (in Dollars)

'

'

'

20,000

20,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Prepaid Insurance (in Dollars)

'

'

'

28,000

28,000

'

'

'

74,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Property, Plant and Equipment, Useful Life

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'3 years

'10 years

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Depreciation (in Dollars)

'

'

'

1,000

1,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Indefinite-Lived Intangible Assets (Excluding Goodwill) (in Dollars)

'

'

'

0

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Finite-Lived Intangible Asset, Useful Life

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'7 years

'14 years

Impairment of Intangible Assets (Excluding Goodwill) (in Dollars)

'

'

'

'

$0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Note_1_Organization_and_Summar3

Note 1 - Organization and Summary of Significant Accounting Policies (Details) - Earnings Per Share (USD $)	3 Months Ended				6 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Jun. 30, 2014		Jun. 30, 2013		Jun. 30, 2014		Jun. 30, 2013
Note 1 - Organization and Summary of Significant Accounting Policies (Details) - Earnings Per Share [Line Items]	'		'		'		'
Net loss per common share — basic and diluted	($0.40)		($0.17)		($0.08)		($0.32)
Weighted average number of common shares outstanding – basic and diluted	13,889	[1]	9,042	[1]	11,756	[1]	8,941	[1]
Scenario, Previously Reported [Member]	'		'		'		'
Note 1 - Organization and Summary of Significant Accounting Policies (Details) - Earnings Per Share [Line Items]	'		'		'		'
Net loss per common share — basic and diluted	($0.28)		'		($0.06)		'
Weighted average number of common shares outstanding – basic and diluted	19,913		'		14,758		'
Restatement Adjustment [Member]	'		'		'		'
Note 1 - Organization and Summary of Significant Accounting Policies (Details) - Earnings Per Share [Line Items]	'		'		'		'
Net loss per common share — basic and diluted	($0.12)		'		($0.02)		'
Weighted average number of common shares outstanding – basic and diluted	-6,024		'		-3,002		'
[1]	The following stock options, warrants and shares issuable under right to shares agreements, investor relations consulting agreement and upon conversion of convertible notes payable outstanding at June 30, 2014 and 2013 were not included in the computation of dilutive loss per share because the net effect would have been anti-dilutive:

Note_2_Acquisition_Details_Acq

Note 2 - Acquisition (Details) - Acquisitions (VeriTeQ Corporation [Member], USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014
VeriTeQ Corporation [Member]	'
Business Acquisition [Line Items]	'
VeriTeQ Corporation	8-Jul-13
VeriTeQ Corporation	$935

Note_2_Acquisition_Details_VC_

Note 2 - Acquisition (Details) - VC Pro Forma Information (USD $)	6 Months Ended
	Jun. 30, 2013
VC Pro Forma Information [Abstract]	'
Loss from continuing operations	($3,208)
Loss per common share from continuing operations– basic and diluted	($0.35)

Note_3_Intangible_Assets_Detai

Note 3 - Intangible Assets (Details) (USD $)	3 Months Ended		6 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Disclosure Text Block [Abstract]	'	'	'	'
Amortization of Intangible Assets	$0.10	$0.10	$0.30	$0.30

Note_3_Intangible_Assets_Detai1

Note 3 - Intangible Assets (Details) - Intangibles and Other Assets (USD $)	6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Dec. 31, 2013
Note 3 - Intangible Assets (Details) - Intangibles and Other Assets [Line Items]	'	'
Intangible asset	$6,721	$7,018
Technology-Based Intangible Assets [Member]	'	'
Note 3 - Intangible Assets (Details) - Intangibles and Other Assets [Line Items]	'	'
Intangible asset	5,998	6,244
Intangible asset estimated useful life	'14 years	'
Customer Relationships [Member]	'	'
Note 3 - Intangible Assets (Details) - Intangibles and Other Assets [Line Items]	'	'
Intangible asset	324	359
Intangible asset estimated useful life	'7 years	'
Trademarks [Member]	'	'
Note 3 - Intangible Assets (Details) - Intangibles and Other Assets [Line Items]	'	'
Intangible asset	$399	$415
Intangible asset estimated useful life	'14 years	'

Note_3_Intangible_Assets_Detai2

Note 3 - Intangible Assets (Details) - Intangibles and Other Assets (Parentheticals) (USD $)	Jun. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Technology-Based Intangible Assets [Member]	'	'
Note 3 - Intangible Assets (Details) - Intangibles and Other Assets (Parentheticals) [Line Items]	'	'
Intangible asset, accumulated amortization	$873	$627
Customer Relationships [Member]	'	'
Note 3 - Intangible Assets (Details) - Intangibles and Other Assets (Parentheticals) [Line Items]	'	'
Intangible asset, accumulated amortization	176	141
Trademarks [Member]	'	'
Note 3 - Intangible Assets (Details) - Intangibles and Other Assets (Parentheticals) [Line Items]	'	'
Intangible asset, accumulated amortization	$51	$35

Note_4_Accrued_Expenses_Detail

Note 4 - Accrued Expenses (Details) - Significant Components of Accrued Expenses (USD $)	Jun. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Significant Components of Accrued Expenses [Abstract]	'	'
Accrued payroll and payroll related	$2,315	$1,734
Accrued legal	454	445
Accrued other expenses	811	539
Total accrued expenses	$3,580	$2,718

Note_5_Notes_Payable_and_Restr2

Note 5 - Notes Payable and Restricted Cash (Details) (USD $)

0 Months Ended

3 Months Ended

6 Months Ended

31 Months Ended

0 Months Ended

0 Months Ended

1 Months Ended

0 Months Ended

0 Months Ended

1 Months Ended

0 Months Ended

Jun. 16, 2014

Nov. 13, 2013

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2014

Mar. 31, 2014

Apr. 03, 2014

Jul. 16, 2014

Jul. 15, 2014

Aug. 12, 2014

Jul. 15, 2014

Jun. 30, 2014

30-May-14

30-May-14

Nov. 13, 2013

Nov. 13, 2013

Nov. 21, 2013

Nov. 13, 2013

30-May-14

Nov. 13, 2013

Nov. 13, 2013

Nov. 13, 2013

Nov. 13, 2013

Nov. 13, 2013

Nov. 21, 2013

Jun. 16, 2014

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Reset Provision [Member]

Prior To Reset Provision [Member]

Net of Investor Expenses and Restricted Proceeds [Member]

Placement Agent [Member]

MGT Capital Investments Inc. [Member]

Investors [Member]

Investors [Member]

Placement Agent [Member]

Investors and Placement Agent [Member]

Letter Agreement [Member]

Investors, Placement Agent, And Letter Agreement [Member]

Proceeds from Financing [Member]

Proceeds from Sale of Marketable Securities [Member]

Pre-Pay Portion Of Outstanding Note [Member]

Investors [Member]

Investors [Member]

Investors [Member]

Investors [Member]

Investors [Member]

Investors [Member]

Investors [Member]

Investors [Member]

Investors [Member]

Investors [Member]

Note 5 - Notes Payable and Restricted Cash (Details) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Convertible Notes Payable

'

$1,816,667

'

'

'

'

'

'

'

$500,000

$83,500

$1,413,000

'

'

$1,816,667

'

'

'

'

$1,816,667

$300,000

'

'

'

'

'

'

'

Debt Instrument, Unamortized Discount

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

166,667

'

'

'

'

'

'

'

'

Debt Instrument, Face Amount

'

'

3,300,000

'

3,300,000

'

3,300,000

'

'

'

'

'

'

'

'

'

'

'

'

1,650,000

'

'

'

'

'

'

'

'

Debt Instrument, Increase (Decrease), Other, Net

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

150,000

'

'

'

'

'

'

'

'

Proceeds from Issuance of Debt

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

635,000

'

'

1,500,000

'

'

'

'

'

'

'

'

Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)

'

'

'

'

'

'

'

'

'

'

'

38,787,016

38,787,016

'

41,811,114

2,944,444

'

'

'

2,422,222

'

222,222

2,644,444

'

2,944,444

'

'

'

Debt Issuance Cost

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

150,000

'

115,000

'

'

'

'

'

'

'

'

Percent of Warrant Proceeds Placement Agent

'

5.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Class of Warrant or Right, Outstanding (in Shares)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

222,222

'

300,000

'

'

'

'

Increase in Restricted Cash

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

750,000

132,500

'

Sale of Stock, Number of Shares Issued in Transaction (in Shares)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

50,000

'

'

'

'

'

'

'

'

'

Restricted Cash and Cash Equivalents

'

'

'

'

'

'

'

900,000

'

'

'

'

'

47,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Increase (Decrease) in Restricted Cash

300,000

'

'

'

-835,000

'

47,000

'

145,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

400,000

Debt Instrument, Convertible, Conversion Price (in Dollars per share)

'

$0.75

$0.20

'

$0.20

'

$0.20

'

'

$0.14

'

'

$0.08

'

$0.20

$0.75

'

'

'

$0.75

$0.20

'

'

'

'

'

'

'

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)

'

'

'

'

'

'

'

'

'

'

'

$0.08

$0.08

'

$0.20

$2.84

'

'

'

$2.84

$0.20

'

'

'

'

'

'

'

Interest Expense, Debt

'

'

$1,100,000

$300,000

$1,600,000

$400,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Note_5_Notes_Payable_and_Restr3

Note 5 - Notes Payable and Restricted Cash (Details) - Notes Payable and Long-term Debt (USD $)	Jun. 30, 2014		Dec. 31, 2013
In Thousands, unless otherwise specified
Note 5 - Notes Payable and Restricted Cash (Details) - Notes Payable and Long-term Debt [Line Items]	'		'
Note payable	$1,250		$467
Less: Current maturities	-1,250		-467
Non-interest bearing subordinated convertible note payable with a principal amount of $3,300 dated December 3, 2012. Note is convertible into common stock equal to 1/3 of the shares beneficially held by the CEO on the date of conversion. Note was amended in July 2013 to extend the maturity date to June 2015. The note was recorded at its fair value and will be revalued at each reporting period with changes in the fair value recorded as other expense/income.	2,137		4,925
Chief Executive Officer [Member] | Demand Note October 11, 2013 [Member]	'		'
Note 5 - Notes Payable and Restricted Cash (Details) - Notes Payable and Long-term Debt [Line Items]	'		'
Note payable Related Party	'	[1]	30	[1]
Chief Executive Officer [Member] | Demand Note October 29, 2013 [Member] | Secured Debt [Member]	'		'
Note 5 - Notes Payable and Restricted Cash (Details) - Notes Payable and Long-term Debt [Line Items]	'		'
Note payable Related Party	691	[2]	232	[2]
Chief Executive Officer [Member] | Demand Note October 29, 2013 [Member]	'		'
Note 5 - Notes Payable and Restricted Cash (Details) - Notes Payable and Long-term Debt [Line Items]	'		'
Note payable Related Party	26	[1]	30	[1]
Chief Executive Officer [Member] | Demand Note [Member]	'		'
Note 5 - Notes Payable and Restricted Cash (Details) - Notes Payable and Long-term Debt [Line Items]	'		'
Note payable Related Party	60	[1]	'	[1]
Chief Financial Officer [Member] | Demand Note [Member]	'		'
Note 5 - Notes Payable and Restricted Cash (Details) - Notes Payable and Long-term Debt [Line Items]	'		'
Note payable Related Party	60	[1]	'	[1]
President [Member] | Demand Note [Member] | Corbin Properties LLC [Member]	'		'
Note 5 - Notes Payable and Restricted Cash (Details) - Notes Payable and Long-term Debt [Line Items]	'		'
Note payable	175		'
President [Member] | Demand Note [Member]	'		'
Note 5 - Notes Payable and Restricted Cash (Details) - Notes Payable and Long-term Debt [Line Items]	'		'
Note payable Related Party	40	[1]	'	[1]
Director [Member] | Demand Note [Member]	'		'
Note 5 - Notes Payable and Restricted Cash (Details) - Notes Payable and Long-term Debt [Line Items]	'		'
Note payable Related Party	25	[1]	'	[1]
Director [Member] | Note Issued March 5, 2014 [Member] | Deephaven Enterprises, Inc. [Member]	'		'
Note 5 - Notes Payable and Restricted Cash (Details) - Notes Payable and Long-term Debt [Line Items]	'		'
Note payable	3		'
Director [Member] | Note Issued March 5, 2014 [Member] | James Rybicki Trust [Member]	'		'
Note 5 - Notes Payable and Restricted Cash (Details) - Notes Payable and Long-term Debt [Line Items]	'		'
Note payable	3		'
Director [Member] | Note Issued March 5, 2014 [Member] | Investors [Member]	'		'
Note 5 - Notes Payable and Restricted Cash (Details) - Notes Payable and Long-term Debt [Line Items]	'		'
Note payable	19		'
Director [Member] | Note Issued March 20, 2014 [Member] | Deephaven Enterprises, Inc. [Member]	'		'
Note 5 - Notes Payable and Restricted Cash (Details) - Notes Payable and Long-term Debt [Line Items]	'		'
Note payable	18	[2]	'	[2]
Director [Member] | Note Issued April 16, 2014 [Member] | William Caragol [Member]	'		'
Note 5 - Notes Payable and Restricted Cash (Details) - Notes Payable and Long-term Debt [Line Items]	'		'
Note payable	2		'
Director [Member] | Note Issued April 16, 2014 [Member] | Ned Siegel [Member]	'		'
Note 5 - Notes Payable and Restricted Cash (Details) - Notes Payable and Long-term Debt [Line Items]	'		'
Note payable Related Party	3	[1]	'	[1]
Director [Member] | Note Issued May 1, 2014 [Member] | Ned Siegel [Member]	'		'
Note 5 - Notes Payable and Restricted Cash (Details) - Notes Payable and Long-term Debt [Line Items]	'		'
Note payable Related Party	2	[1],[2]	'	[1],[2]
Director [Member] | Note Payable, No Interest [Member] | Investors [Member]	'		'
Note 5 - Notes Payable and Restricted Cash (Details) - Notes Payable and Long-term Debt [Line Items]	'		'
Note payable	8		'
PositiveID [Member]	'		'
Note 5 - Notes Payable and Restricted Cash (Details) - Notes Payable and Long-term Debt [Line Items]	'		'
Note payable Related Party	$115	[2],[3]	$175	[2],[3]
[1]	These notes have been issued to related parties. See Note 10.
[2]	The warrants are more fully described in Note 7.
[3]	This note when originally issued was issued to a related party. See Note 10.

Note_5_Notes_Payable_and_Restr4

Note 5 - Notes Payable and Restricted Cash (Details) - Notes Payable and Long-term Debt (Parentheticals) (USD $)

Jun. 30, 2014

Dec. 31, 2013

Nov. 13, 2013

Oct. 18, 2013

Jun. 30, 2014

Jun. 30, 2014

Jun. 30, 2014

Dec. 31, 2013

Jun. 30, 2014

Dec. 31, 2013

Jun. 30, 2014

Jun. 30, 2014

Dec. 31, 2013

Jun. 30, 2014

Jun. 30, 2014

Jun. 30, 2014

Jun. 30, 2014

Jun. 30, 2014

Jun. 30, 2014

Jun. 30, 2014

Jun. 30, 2014

Jun. 30, 2014

Jun. 30, 2014

Jun. 30, 2014

Jun. 30, 2014

Jun. 30, 2014

Jun. 30, 2014

Jun. 30, 2014

Dec. 31, 2013

30-May-14

Nov. 13, 2013

Chief Executive Officer [Member]

Chief Executive Officer [Member]

Chief Executive Officer [Member]

Chief Executive Officer [Member]

Chief Executive Officer [Member]

Chief Executive Officer [Member]

Chief Executive Officer [Member]

Chief Executive Officer [Member]

Chief Executive Officer [Member]

Chief Financial Officer [Member]

President [Member]

President [Member]

Director [Member]

Director [Member]

Director [Member]

Director [Member]

Director [Member]

Director [Member]

Director [Member]

Director [Member]

Director [Member]

Director [Member]

Director [Member]

PositiveID [Member]

PositiveID [Member]

Investors [Member]

Investors [Member]

Convertible Note, Warrants Reset [Member]

Demand Note October 11, 2013 [Member]

Demand Note October 29, 2013 [Member]

Demand Note October 29, 2013 [Member]

Demand Note October 29, 2013 [Member]

Demand Note October 29, 2013 [Member]

Demand Note [Member]

Subordinated Debt [Member]

Subordinated Debt [Member]

Demand Note [Member]

Demand Note [Member]

Demand Note [Member]

Originally Issued [Member]

Demand Note [Member]

Note Issued March 5, 2014 [Member]

Note Issued March 5, 2014 [Member]

Note Issued March 5, 2014 [Member]

Note Issued March 5, 2014 [Member]

Note Issued March 20, 2014 [Member]

Note Issued April 16, 2014 [Member]

Note Issued April 16, 2014 [Member]

Note Issued May 1, 2014 [Member]

Note Payable, No Interest [Member]

Demand Note October 29, 2013 [Member]

Secured Debt [Member]

Secured Debt [Member]

Corbin Properties LLC [Member]

Note Issued March 5, 2014 [Member]

Deephaven Enterprises, Inc. [Member]

James Rybicki Trust [Member]

William Caragol [Member]

Investors [Member]

Deephaven Enterprises, Inc. [Member]

William Caragol [Member]

Ned Siegel [Member]

Ned Siegel [Member]

Investors [Member]

Secured Debt [Member]

Investors [Member]

Note 5 - Notes Payable and Restricted Cash (Details) - Notes Payable and Long-term Debt (Parentheticals) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Note face amount

$3,300,000

'

'

'

'

$80,000

$1,817,000

$1,817,000

$30,000

'

$60,000

$3,300,000

$3,300,000

$60,000

$175,000

$40,000

'

$25,000

$25,000

$25,000

$25,000

$222,000

$61,000

$25,000

$30,000

$30,000

$100,000

$200,000

$200,000

'

$1,650,000

Interest

'

'

'

'

'

5.00%

'

'

5.00%

5.00%

5.00%

'

'

5.00%

10.00%

5.00%

'

5.00%

9.00%

9.00%

9.00%

'

9.00%

9.00%

9.00%

9.00%

'

5.00%

5.00%

'

'

Converted amount

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

60,000

'

'

'

Converted interest

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

10,000

'

'

'

Converted shares (in Shares)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

47,000

'

'

'

Warrants (in Shares)

'

'

'

'

34,396,000

'

2,644,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

300,000

'

'

100,000

'

300,000

'

'

2,422,222

Discount

'

'

'

'

'

'

892,000

1,585,000

'

'

'

'

'

'

'

'

22,000

'

22,000

22,000

25,000

203,000

43,000

23,000

27,000

18,000

92,000

'

'

'

166,667

Conversion price (in Dollars per share)

$0.20

'

$0.75

'

'

'

$0.20

'

'

'

'

'

'

'

'

'

'

'

$0.35

$0.35

'

$0.20

'

$0.35

$0.35

'

$0.20

'

'

$0.20

$0.75

Warrants exercise price (in Dollars per share)

'

'

'

'

'

'

$2.84

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0.35

'

'

$0.35

'

'

'

$0.20

$2.84

Repaid, net of discount

'

'

'

'

'

'

$400,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Outstanding on June 30, 2014 (in Shares)

41,480,000

9,459,000

'

9,302,674

'

'

8,099,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Conversion Percentage

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

60.00%

'

'

60.00%

'

'

'

'

'

'

'

Note_6_Financial_Instruments_D

Note 6 - Financial Instruments (Details) (USD $)	Jun. 30, 2014	Nov. 13, 2013	Jun. 30, 2014	Dec. 31, 2013	Jun. 30, 2014	Dec. 31, 2013	Jun. 30, 2014	Dec. 31, 2013	Jun. 30, 2014	Jun. 30, 2014	Dec. 31, 2013
			Warrant [Member]	Warrant [Member]	Notes [Member]	Notes [Member]	Estimated Royalty Obligations [Member]	Estimated Royalty Obligations [Member]	Estimated Royalty Obligations [Member]	Estimated Royalty Obligations [Member]	Convertible Subordinated Debt [Member]
									Minimum [Member]	Maximum [Member]
Note 6 - Financial Instruments (Details) [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Fair Value Assumptions, Expected Term	'	'	'4 years 135 days	'	'153 days	'335 days	'	'	'3 years	'14 years	'
Fair Value Assumptions, Expected Volatility Rate	'	'	166.00%	'	0.09%	0.18%	'	'	'	'	'
Fair Value Assumptions, Risk Free Interest Rate	'	'	1.25%	'	'	'	'	'	'	'	'
Fair Value Assumptions, Expected Dividend Rate	'	'	0.00%	'	'	'	'	'	'	'	'
Fair Value Assumptions, Exercise Price (in Dollars per share)	'	'	'	$2.29	$0.14	'	'	'	'	'	'
Debt Instrument, Convertible, Conversion Price (in Dollars per share)	$0.20	$0.75	'	'	$0.20	$0.75	'	'	'	'	'
Fair Value Inputs, Discount Rate	'	'	'	'	'	'	'	'	25.00%	60.00%	'
Debt Instrument, Face Amount (in Dollars)	$3,300,000	'	'	'	'	'	'	'	'	'	$3,300,000
Accrued Royalties (in Dollars)	$160,000	'	'	'	'	'	$4,000,000	$4,000,000	'	'	'

Note_6_Financial_Instruments_D1

Note 6 - Financial Instruments (Details) - Assets and Liabilities Measured at Fair Value (USD $)	Jun. 30, 2014		Dec. 31, 2013	Nov. 13, 2013
Liabilities:	'		'	'
Subordinated convertible note with an embedded conversion option	$2,137,000		$4,925,000	'
Embedded conversion option of the convertible notes	'		'	1,816,667
Royalty obligations	3,840,000		3,940,000	'
Warrant [Member] | Fair Value, Inputs, Level 3 [Member]	'		'	'
Liabilities:	'		'	'
Warrant liabilities	1,962,000		6,114,000	'
Warrant [Member]	'		'	'
Liabilities:	'		'	'
Warrant liabilities	1,962,000	[1]	6,114,000	'
Fair Value, Inputs, Level 3 [Member]	'		'	'
Liabilities:	'		'	'
Subordinated convertible note with an embedded conversion option	2,137,000		4,925,000	'
Embedded conversion option of the convertible notes	125,000		3,124,000	'
Royalty obligations	$4,000,000		$4,000,000	'
[1]	Includes $160 thousand of current royalty obligations in account payable and accrued expenses at June 30, 2014.

Note_6_Financial_Instruments_D2

Note 6 - Financial Instruments (Details) - Level 3 Liabilities Activity (USD $)	3 Months Ended	6 Months Ended	31 Months Ended		6 Months Ended				6 Months Ended
	Jun. 30, 2014	Jun. 30, 2014	Jun. 30, 2014	Nov. 13, 2013	Jun. 30, 2014		Jun. 30, 2014	Dec. 31, 2013	Jun. 30, 2014		Jun. 30, 2014
					Warrant [Member]		Estimated Royalty Obligations [Member]	Estimated Royalty Obligations [Member]	Convertible Subordinated Debt [Member]		Embedded Derivative Financial Instruments [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'	'	'	'	'		'	'	'		'
Balance at December 31, 2013	'	$4,925,000	'	'	'		'	'	$4,925,000		'
Balance at December 31, 2013	'	'	'	1,816,667	'		'	'	'		3,124,000
Balance at December 31, 2013	'	'	'	'	6,114,000		'	'	'		'
Balance at December 31, 2013	'	'	'	'	'		4,000,000	4,000,000	'		'
Increase due to embedded conversion option for May 30, 2014 convertible notes payable	'	'	'	'	'		'	'	'		629,000
Change in fair value	'	'	'	'	2,838,000		'	'	-2,788,000		'
Change in fair value	5,961,000	2,838,000	4,107,000	'	'		'	'	'		-3,628,000
Change in fair value	'	'	'	'	2,838,000		'	'	-2,788,000		'
Exercise of warrants under Right to Shares Agreements	'	'	'	'	-6,990,000		'	'	'		'
Balance at June 30, 2014	2,137,000	2,137,000	2,137,000	'	'		'	'	2,137,000	[1]	'
Balance at June 30, 2014	'	'	'	1,816,667	'		'	'	'		125,000
Balance at June 30, 2014	'	'	'	'	1,962,000	[2]	'	'	'		'
Balance at June 30, 2014	$160,000	$160,000	$160,000	'	'		$4,000,000	$4,000,000	'		'
[1]	The principal balance at December 31, 2013 and June 30, 2014 is $3.3 million. See Note 5 for additional information regarding the note.
[2]	Includes $160 thousand of current royalty obligations in account payable and accrued expenses at June 30, 2014.

Note_7_Stockholders_Deficit_De

Note 7 - Stockholders' Deficit (Details) (USD $)

1 Months Ended

3 Months Ended

6 Months Ended

31 Months Ended

3 Months Ended

6 Months Ended

3 Months Ended

1 Months Ended

3 Months Ended

6 Months Ended

Jun. 30, 2014

Jan. 31, 2013

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2014

Jun. 18, 2014

Jun. 17, 2014

Dec. 31, 2013

Oct. 18, 2013

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2013

Jun. 30, 2014

Oct. 17, 2013

Jul. 12, 2013

Jun. 30, 2014

Jun. 30, 2014

30-May-14

30-May-14

30-May-14

30-May-14

Nov. 13, 2013

30-May-14

Nov. 13, 2013

Jun. 30, 2014

Jun. 30, 2014

Jun. 30, 2014

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2014

Beneficial Owner [Member]

Directors, Employees, And Consultants [Member]

Directors, Employees, And Consultants [Member]

Series C Preferred Stock [Member]

Series C Preferred Stock [Member]

Series C Preferred Stock [Member]

Series B, C, D, E, F, G and H Warrants [Member]

Series C, G, and H Warrants [Member]

Series C, G, and H Warrants [Member]

Series C, G, and H Warrants [Member]

Series C, G, and H Warrants [Member]

Series VTa Warrant [Member]

Series VTa Warrant [Member]

Series VTb Warrants [Member]

Series VTb Warrants [Member]

Series I And J Warrants [Member]

Excluding Issuable Shares [Member]

Restricted Stock [Member]

Restricted Stock [Member]

Restricted Stock [Member]

Restricted Stock [Member]

Restricted Stock [Member]

Future Event 08/26/14 [Member]

Chief Executive Officer [Member]

Minimum [Member]

Maximum [Member]

Share-based Compensation Award, Tranche One [Member]

Note 7 - Stockholders' Deficit (Details) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred Stock, Shares Authorized

5,000,000

'

5,000,000

'

5,000,000

'

5,000,000

'

'

5,000,000

'

'

'

'

500,000

500,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred Stock, Par or Stated Value Per Share (in Dollars per share)

$10

'

$10

'

$10

'

$10

$0.01

$10

$10

'

'

'

'

'

'

$10

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0.01

Preferred Stock, Shares Outstanding

0

'

0

'

0

'

0

'

'

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common Stock, Shares Authorized

50,000,000

'

50,000,000

'

50,000,000

'

50,000,000

500,000,000

50,000,000

50,000,000

50,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

500,000,000

Common Stock, Shares, Issued

41,480,000

'

41,480,000

'

41,480,000

'

41,480,000

'

'

9,459,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

12,400,000

'

'

'

'

'

'

Common Stock, Shares, Outstanding

41,480,000

'

41,480,000

'

41,480,000

'

41,480,000

'

'

9,459,000

9,302,674

5,700,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

12,400,000

'

'

'

'

'

'

Warrants and Rights Outstanding (in Dollars)

$1,962,000

'

$1,962,000

'

$1,962,000

'

$1,962,000

'

'

$6,114,000

'

'

'

'

'

'

'

$300,000

'

'

'

'

'

'

'

'

$100,000

'

'

'

'

'

'

'

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0.35

$1.31

$1.57

$0.20

$2.84

$0.20

$2.84

'

'

'

'

'

'

'

'

Interest Expense (in Dollars)

'

'

1,131,000

253,000

1,592,000

446,000

8,821,000

'

'

'

'

'

'

'

'

'

'

'

7,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Class of Warrant or Right, Number of Securities Called by Warrants or Rights

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

37,551,144

2,644,444

4,260,000

300,000

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

'

'

'

0

0

1,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value (in Dollars per share)

'

'

'

'

'

$1.33

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term

'

'

'

'

'

'5 years

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate

'

'

'

'

'

126.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate

'

'

'

'

'

0.83%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate

'

'

'

'

'

0.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Allocated Share-based Compensation Expense (in Dollars)

'

'

0

'

0

'

'

'

'

'

'

'

400,000

600,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

200,000

200,000

400,000

300,000

'

Share Price (in Dollars per share)

$0.14

'

$0.14

'

$0.14

'

$0.14

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period

'

'

0

'

382,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value (in Dollars)

'

'

'

'

400,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value (in Dollars)

'

'

0

'

'

400,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares

'

'

'

3

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options (in Dollars)

0

'

0

'

0

'

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Issued During Period, Value, Restricted Stock Award, Gross (in Dollars)

$600,000

'

'

'

$1,500,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share Based Compensation Arrangement By Share Based Payment Award, Equity Instruments Other Than Options, Number of Shares Expected To Vest

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

150,000

'

'

'

'

'

Stock Issued During Period, Shares, Restricted Stock Award, Gross

'

900,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Note_7_Stockholders_Deficit_De1

Note 7 - Stockholders' Deficit (Details) - Warrants Exercisable (USD $)	5 Months Ended	6 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Jun. 03, 2014	Jun. 30, 2014
Class of Warrant or Right [Line Items]	'	'
Warrants Authorized	'	42,647
Warrants Issued	'	2,966
Balance (in Dollars)	'	$16,255
Exercised/Forfeited	-29,358	'
Series A Warrant [Member]	'	'
Class of Warrant or Right [Line Items]	'	'
Warrants Authorized	'	95
Exercise Price (in Dollars per share)	'	$0.37
Exercisable Period	'	'3 years
Exercised/Forfeited	-95	'
Series B Warrant [Member]	'	'
Class of Warrant or Right [Line Items]	'	'
Warrants Authorized	'	40
Balance (in Dollars)	'	40
Exercise Price (in Dollars per share)	'	$1.57
Exercisable Period	'	'3 years
Series C Warrant [Member]	'	'
Class of Warrant or Right [Line Items]	'	'
Warrants Authorized	'	20
Balance (in Dollars)	'	20
Exercise Price (in Dollars per share)	'	$1.57
Exercisable Period	'	'3 years
Series C Warrant Reset [Member]	'	'
Class of Warrant or Right [Line Items]	'	'
Warrants Authorized	'	20
Balance (in Dollars)	'	20
Exercise Price (in Dollars per share)	'	$0.35
Exercisable Period	'	'3 years
Series D Warrant [Member]	'	'
Class of Warrant or Right [Line Items]	'	'
Warrants Authorized	'	14
Balance (in Dollars)	'	14
Exercise Price (in Dollars per share)	'	$1.57
Exercisable Period	'	'5 years
Series E Warrant [Member]	'	'
Class of Warrant or Right [Line Items]	'	'
Warrants Authorized	'	29
Balance (in Dollars)	'	29
Exercise Price (in Dollars per share)	'	$1.57
Exercisable Period	'	'5 years
Series F Warrant [Member]	'	'
Class of Warrant or Right [Line Items]	'	'
Warrants Authorized	'	40
Balance (in Dollars)	'	40
Exercise Price (in Dollars per share)	'	$1.57
Exercisable Period	'	'3 years
Series G Warrant [Member]	'	'
Class of Warrant or Right [Line Items]	'	'
Warrants Authorized	'	47
Balance (in Dollars)	'	47
Exercise Price (in Dollars per share)	'	$1.31
Exercisable Period	'	'3 years
Series G Warrant Reset [Member]	'	'
Class of Warrant or Right [Line Items]	'	'
Warrants Authorized	'	48
Balance (in Dollars)	'	48
Exercise Price (in Dollars per share)	'	$0.35
Exercisable Period	'	'3 years
Series H Warrant [Member]	'	'
Class of Warrant or Right [Line Items]	'	'
Warrants Authorized	'	63
Balance (in Dollars)	'	63
Exercise Price (in Dollars per share)	'	$1.57
Exercisable Period	'	'3 years
Series H Warrant Reset [Member]	'	'
Class of Warrant or Right [Line Items]	'	'
Warrants Authorized	'	20
Balance (in Dollars)	'	20
Exercise Price (in Dollars per share)	'	$0.35
Exercisable Period	'	'3 years
Series VT a Warrant [Member]	'	'
Class of Warrant or Right [Line Items]	'	'
Warrants Authorized	'	37,551
Warrants Issued	'	2,966
Balance (in Dollars)	'	11,254
Exercise Price (in Dollars per share)	'	$0.20
Exercisable Period	'	'5 years
Exercised/Forfeited	-29,263	'
Series VT b Warrant [Member]	'	'
Class of Warrant or Right [Line Items]	'	'
Warrants Authorized	'	4,260
Balance (in Dollars)	'	4,260
Exercise Price (in Dollars per share)	'	$0.20
Exercisable Period	'	'5 years
Series I Warrant [Member]	'	'
Class of Warrant or Right [Line Items]	'	'
Warrants Authorized	'	300
Balance (in Dollars)	'	300
Exercise Price (in Dollars per share)	'	$0.35
Exercisable Period	'	'3 years
Series J Warrant [Member]	'	'
Class of Warrant or Right [Line Items]	'	'
Warrants Authorized	'	100
Balance (in Dollars)	'	$100
Exercise Price (in Dollars per share)	'	$0.35
Exercisable Period	'	'2 years

Note_7_Stockholders_Deficit_De2

Note 7 - Stockholders' Deficit (Details) - Fair Value of Warrants Assumptions (Warrant [Member])	0 Months Ended					1 Months Ended			12 Months Ended	14 Months Ended	20 Months Ended
	Jun. 02, 2013	30-May-13	Apr. 10, 2013	Oct. 12, 2012	Jun. 02, 2012	Mar. 18, 2013	Dec. 31, 2012	Sep. 25, 2012	30-May-14	30-May-14	30-May-14
Note 7 - Stockholders' Deficit (Details) - Fair Value of Warrants Assumptions [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Dividend yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Volatility	126.00%	163.00%	126.00%	126.00%	126.00%	126.00%	126.00%	126.00%	215.00%	210.00%	223.00%
Expected lives	'3 years	'4 years 167 days	'3 years	'3 years	'3 years	'3 years	'5 years	'3 years	'2 years 3 days	'1 year 317 days	'1 year 135 days
Risk-free rate	0.52%	1.54%	0.34%	0.35%	0.34%	0.38%	0.72%	0.35%	0.37%	0.37%	0.10%
Series I Warrant [Member]	'	'	'	'	'	'	'	'	'	'	'
Note 7 - Stockholders' Deficit (Details) - Fair Value of Warrants Assumptions [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Dividend yield	'	0.00%	'	'	'	'	'	'	'	'	'
Volatility	'	192.26%	'	'	'	'	'	'	'	'	'
Expected lives	'	'2 years 292 days	'	'	'	'	'	'	'	'	'
Risk-free rate	'	0.79%	'	'	'	'	'	'	'	'	'
Series J Warrant [Member]	'	'	'	'	'	'	'	'	'	'	'
Note 7 - Stockholders' Deficit (Details) - Fair Value of Warrants Assumptions [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Dividend yield	'	0.00%	'	'	'	'	'	'	'	'	'
Volatility	'	214.78%	'	'	'	'	'	'	'	'	'
Expected lives	'	'2 years	'	'	'	'	'	'	'	'	'
Risk-free rate	'	0.39%	'	'	'	'	'	'	'	'	'

Note_7_Stockholders_Deficit_De3

Note 7 - Stockholders' Deficit (Details) - Stock Option Activity (USD $)	3 Months Ended		6 Months Ended
In Thousands, except Share data, unless otherwise specified	Jun. 30, 2014		Jun. 30, 2014
Stock Option Activity [Abstract]	'		'
Outstanding at January 1, 2014	'		2,628,000
Outstanding at January 1, 2014 (in Dollars per share)	'		$9.01
Exercised	0		-382,000
Exercised (in Dollars per share)	'		$0.05
Forfeited or expired	'		-8,000
Forfeited or expired (in Dollars per share)	'		$659.87
Outstanding at June 30, 2014	2,238,000		2,238,000
Outstanding at June 30, 2014 (in Dollars per share)	$8.02		$8.02
Outstanding at June 30, 2014	'		'4 years 237 days
Outstanding at June 30, 2014 (in Dollars)	$77,000	[1]	$77,000	[1]
Vested or expected to vest at June 30, 2014	2,238,000		2,238,000
Vested or expected to vest at June 30, 2014 (in Dollars per share)	$8.02		$8.02
Vested or expected to vest at June 30, 2014	'		'4 years 237 days
Vested or expected to vest at June 30, 2014 (in Dollars)	$77,000	[1]	$77,000	[1]
Shares available on June 30, 2014 for options that may be granted	2,508,000		2,508,000
[1]	The intrinsic value of a stock option is the amount by which the market value of the underlying stock exceeds the exercise price of the option. The market value of our common stock was $0.14 per share at June 30, 2014.

Note_8_Income_Taxes_Details

Note 8 - Income Taxes (Details) (USD $)	3 Months Ended		6 Months Ended		30 Months Ended	31 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2014
Note 8 - Income Taxes (Details) [Line Items]	'	'	'	'	'	'
Income Tax Expense (Benefit)	$0	$0	$0	$0	($800,000)	($800,000)
Limited Under IRC Section 382 [Member]	'	'	'	'	'	'
Note 8 - Income Taxes (Details) [Line Items]	'	'	'	'	'	'
Operating Loss Carryforwards	7,500,000	'	7,500,000	'	7,500,000	7,500,000
Internal Revenue Service (IRS) [Member]	'	'	'	'	'	'
Note 8 - Income Taxes (Details) [Line Items]	'	'	'	'	'	'
Operating Loss Carryforwards	$11,000,000	'	$11,000,000	'	$11,000,000	$11,000,000

Note_9_Loss_Per_Share_Details_

Note 9 - Loss Per Share (Details) - Basic and Diluted (Loss) Income Per Share (USD $)	3 Months Ended				6 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Jun. 30, 2014		Jun. 30, 2013		Jun. 30, 2014		Jun. 30, 2013
Numerator for basic and diluted loss per share:	'		'		'		'
Loss from continuing operations	($5,558)		($1,542)		($933)		($2,852)
Denominator for basic and diluted loss per share:	'		'		'		'
Basic and diluted weighted-average shares outstanding (1)	13,889	[1]	9,042	[1]	11,756	[1]	8,941	[1]
Loss per share— basic and diluted:	'		'		'		'
Total — basic and diluted	($0.40)		($0.17)		($0.08)		($0.32)
[1]	The following stock options, warrants and shares issuable under right to shares agreements, investor relations consulting agreement and upon conversion of convertible notes payable outstanding at June 30, 2014 and 2013 were not included in the computation of dilutive loss per share because the net effect would have been anti-dilutive:

Note_9_Loss_Per_Share_Details_1

Note 9 - Loss Per Share (Details) - Antidilutive Securities	6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Anti-dilutive securities	28,732	5,333
Equity Option [Member]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Anti-dilutive securities	2,238	2,712
Warrant [Member]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Anti-dilutive securities	16,255	436
Consulting Agreement [Member]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Anti-dilutive securities	200	'
Convertible Debt Securities [Member]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Anti-dilutive securities	10,039	2,185

Note_10_Related_Party_Transact1

Note 10 - Related Party Transactions (Details) (Accrued Expenses [Member], USD $)	Jun. 30, 2014	Dec. 31, 2013
In Millions, unless otherwise specified
Accrued Expenses [Member]	'	'
Note 10 - Related Party Transactions (Details) [Line Items]	'	'
Due to Related Parties, Current	$2	$1.60

Note_11_Commitments_and_Contin1

Note 11 - Commitments and Contingencies (Details)	1 Months Ended
	Mar. 31, 2013	Mar. 31, 2013
	USD ($)	GBP (£)
Commitments and Contingencies Disclosure [Abstract]	'	'
Portion of Purchase Price From Sale of Division to Satisfy Outstanding Liabilities	$61,000	£ 40,000
Third Party Claim to Liquidator	$400,000	£ 244,000

Note_13_Supplemental_Cash_Flow2

Note 13 - Supplemental Cash Flow Information (Details) - Supplemental Cash Flow Information (USD $)	6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2014
		Royalty Expense [Member]	Full Payment of Note Payable [Member]	Partial Payment of Note Payable [Member]	Payment Of Notes Payable [Member]
Note 13 - Supplemental Cash Flow Information (Details) - Supplemental Cash Flow Information [Line Items]	'	'	'	'	'
Royalty obligations now included in accrued expenses	'	$100	'	'	'
Non-cash investing and financing activities:	'	'	'	'	'
Issuance of common stock	'	'	420	70	135
Conversion of promissory note under Right to Shares Agreement	191	'	'	'	'
Issuance of a warrant in connection with a promissory note	66	'	'	'	'
Cashless exercise of warrants	$6,990	'	'	'	'

Note_14_Subsequent_Events_Deta

Note 14 - Subsequent Events (Details) (USD $)

6 Months Ended

12 Months Ended

31 Months Ended

0 Months Ended

0 Months Ended

0 Months Ended

0 Months Ended

0 Months Ended

0 Months Ended

3 Months Ended

0 Months Ended

3 Months Ended

0 Months Ended

3 Months Ended

0 Months Ended

Jun. 30, 2014

Dec. 31, 2012

Jun. 30, 2014

Nov. 13, 2013

Jul. 31, 2014

Aug. 04, 2014

Jul. 15, 2014

Aug. 12, 2014

Jul. 31, 2014

Jul. 31, 2014

Jul. 31, 2014

Jul. 31, 2014

Aug. 04, 2014

Aug. 04, 2014

Aug. 04, 2014

Aug. 04, 2014

Jul. 16, 2014

Jul. 15, 2014

Jul. 16, 2014

Jul. 15, 2014

Jul. 01, 2014

Sep. 30, 2014

Jul. 14, 2014

Sep. 30, 2014

Jul. 15, 2014

Sep. 30, 2014

Jul. 15, 2014

Aug. 12, 2014

Jul. 15, 2014

30-May-14

Nov. 13, 2013

Jun. 30, 2014

8% Buyer Note [Member]

12% Buyer Note [Member]

Convertible Notes Payable [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Investors [Member]

Investors [Member]

RedChip Companies Inc [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

If All Warrants Exercised [Member]

8% Note [Member]

8% Note [Member]

8% Second Note [Member]

8% Second Note [Member]

12% Note [Member]

12% Note [Member]

12% Second Note [Member]

12% Second Note [Member]

Investors [Member]

Investors [Member]

Investors [Member]

Investors [Member]

Hanover Financial Services [Member]

Hanover Financial Services [Member]

SmallCapVoice.com, Inc [Member]

SmallCapVoice.com, Inc [Member]

RedChip Companies Inc [Member]

RedChip Companies Inc [Member]

Investors [Member]

Investors [Member]

Investors [Member]

Investors [Member]

Investors [Member]

Investors [Member]

Investors [Member]

Investors [Member]

Investors [Member]

Investors [Member]

Investors [Member]

Note 14 - Subsequent Events (Details) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Issued During Period, Shares, Issued for Services (in Shares)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

550,000

'

500,000

'

500,000

300,000

'

'

'

'

'

'

Common Stock, Shares Subscribed but Unissued (in Shares)

29,097,000

'

29,097,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

200,000

Stock Issued During Period, Value, Issued for Services (in Dollars)

'

$160,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$77,000

'

$45,000

'

$24,000

'

'

'

'

'

'

Debt Instrument, Convertible, Conversion Price (in Dollars per share)

$0.20

'

$0.20

$0.75

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0.14

'

'

'

'

'

'

'

'

'

$0.08

$0.20

$0.75

'

Debt Conversion, Converted Instrument, Shares Issued (in Shares)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

17,661,115

'

'

'

'

'

Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)

'

'

'

'

'

'

'

144,851,212

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

38,787,016

38,787,016

'

2,422,222

'

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)

'

'

'

'

'

'

'

$0.02

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0.08

$0.08

$0.20

$2.84

'

Convertible Notes Payable (in Dollars)

'

'

'

1,816,667

'

'

'

'

'

75,000

'

75,000

'

50,000

'

50,000

'

'

500,000

83,500

'

'

'

'

'

'

'

1,413,000

'

300,000

1,816,667

'

Debt Instrument, Interest Rate, Stated Percentage

'

'

'

'

'

'

8.00%

'

'

8.00%

'

8.00%

'

12.00%

'

12.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Convertible Note, Maximum Ownership Percent

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

4.99%

4.99%

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Convertible, Threshold Consecutive Trading Days

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'10 days

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Proceeds from Convertible Debt (in Dollars)

-100,000

'

1,550,000

'

'

'

'

'

'

'

'

'

'

'

'

'

125,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Unamortized Discount, Percent Of Principal

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

10.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Convertible Note, Contingent Interest Payment, Percent Of Principal

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

12.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Convertible, Conversion Price, Percent Of Lowest Trade Price

'

'

'

'

'

'

'

'

'

61.00%

'

61.00%

'

61.00%

'

61.00%

'

'

60.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

DebtInstrumentConversion PriceTradingDays

'

'

'

'

'

'

'

'

'15 years

'

'15 days

'

'20 days

'

'20 days

'

'25 days

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Convertible Note, Note Terms, Minimum Penalty For Inproper Registration Of Underlying Stock (in Dollars)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

25,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Redemption Price, Percentage

'

'

'

'

'

'

'

'

150.00%

'

'

'

150.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Financing Receivable, Gross (in Dollars)

'

'

'

'

$75,000

$50,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Notes Receivable Interest Rate

'

'

'

'

8.00%

12.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'